Your browser is no longer supported. Please, upgrade your browser.
Settings
IWM iShares Russell 2000 daily Stock Chart
IWM [NYSE]
iShares Russell 2000
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.04%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.64%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter1.34%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y4.12%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year8.95%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range102.41 - 128.55 Perf YTD2.97%
Dividend1.54 P/FCF- EPS past 5Y- ROI- 52W High-4.88% Beta-
Dividend %1.26% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low19.41% ATR1.60
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)43.06 Volatility1.42% 1.23%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.89 Prev Close121.92
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume31.16M Price122.28
Recom- SMA20-1.30% SMA50-1.92% SMA2001.88% Volume27,831,591 Change0.30%
Jul-30-15 05:31PM  Get ready for the biggest month of US economic data in years
02:45PM  Are Investors Really Panicking In A Historically Boring Market?
01:36PM  Breadth and Major Market Tops
12:40PM  FIDELITY: Baby Boomers own too much stock
11:00AM  Am I bearish or are you just WAY too bullish?
10:21AM  The Greatest Risk of A Market Peak Since 2007
09:22AM  Here's how every part of the US economy did in the second quarter
07:29AM  Here's a super quick guide to what traders are saying right now
02:30AM  Profiting While Lowering Risk
Jul-29-15 05:38PM  ETF Market Vital Signs: Cruise Control at Barrons.com
02:00PM  The Fed is still waiting
08:38AM  Wednesday marks the end of an era at the Federal Reserve
08:04AM  Are The Indices Hiding Problems?
07:42AM  Here's a super quick guide to what traders are talking about right now
Jul-28-15 05:11PM  August: Once the best, now the worst month
12:47PM  ART CASHIN: 'The market is not the random event that academics and other commentators would have you believe'
12:42PM  The U.S. markets have reached a major bull-bear test at MarketWatch
09:15AM  There are more bad charts than good charts in the stock market right now
07:35AM  Here's a super quick guide to what traders are talking about this morning
Jul-27-15 06:13PM  Yikes! 7th Down Friday/Down Monday of 2015 plus 3 Peaks/Domed House Top
04:53PM  2015 has simply not been a fun year in the stock market
12:08PM  Was That A Failed Breakout in Russell2000?
08:00AM  Why these stocks are stuck in a rut at CNBC
07:32AM  Here's what traders are saying about the Chinese stock market 'bloodbath'
Jul-25-15 05:56PM  A Short Term Reversal Point, And A Scenario for S&P to Fall to 1980
08:37AM  The Week Ahead: Can Your Portfolio Survive Earnings Season? at Forbes
08:01AM  What to expect from the stock market this week
07:22AM  Bearish Cracks vs. Be Patient Facts
Jul-24-15 02:49PM  Stocks are rolling over Dow off 160
02:00PM  ChartAdvisor for July 24 2015 at Investopedia
10:46AM  How Should We Think About Past Performance?
01:30AM  3 ETFs Caught In Risk-Off Trade
Jul-23-15 10:59AM  This is the most insanely bullish commentary we've read about the US economy in a while
07:32AM  Here's a super quick guide to what traders are talking about this morning
Jul-22-15 06:43PM  The Best Small Cap Tech Stocks Right Now
09:30AM  A Small-Cap ETF With Big Dividend Growth Potential
Jul-21-15 08:11PM  ETF Market Vital Signs, July 21: S&P 500 Takes a Breath at Barrons.com
06:40PM  What Do 1987, 2003, 2009, And 2015 Have In Common?
07:40AM  Exploring Index Rotation
Jul-20-15 06:03PM  Why stocks are a better trade than ETFs right now at MarketWatch
05:17PM  NASDAQ mid-year rally started late and appears to be ending
04:58PM  If Beautys On The Inside, This Market Wins The Ugly Contest
03:37PM  Last Week Ended With A Green Surprise For Options Traders; Will The Surprises Continue?
Jul-18-15 12:03PM  Market Breadth: How Concerning For The Stock Market?
09:13AM  The Week Ahead: Damn the Torpedoes .... at Forbes
08:01AM  What to expect from the stock market this week
Jul-17-15 02:00PM  ChartAdvisor for July 16 2015 at Investopedia
07:01AM  U.S. small cap: mediocrity lies at the intersection of maximums and minimums
Jul-15-15 09:55AM  Is Elevated Volatility on Modest Losses Normal? ETFguide
08:16AM  'Sparks will fly'
Jul-14-15 08:38PM  5 Highly Rated IBD Stocks Within PowerShares QQQ ETF at Investor's Business Daily
06:02PM  ETF Market Vital Signs, July 14: S&P 500 Riding Four-Day Win Streak at Barrons.com
05:03PM  Retail Sales Data Doesnt Matter To Retailers
08:30AM  Retail flop
07:31AM  Here's a super quick guide to what traders are talking about this morning
Jul-13-15 11:16PM  Paul Tudor Jones on Jesse Livermore
10:54AM  Everyone's favorite joke about how easy it is to make money in the stock market has been a disaster this year
Jul-12-15 06:55PM  Futures aren't doing much after a third straight weekend of non-stop Greece news
Jul-11-15 08:23AM  The Week Ahead: Should You Trust This Rally? at Forbes
08:01AM  What to expect from the stock market this week
07:37AM  What Are The Odds Of A Bullish Resolution?
02:27AM  Seizing Opportunity From Stock Market Volatility at Barrons.com
Jul-10-15 05:49PM  ETF Market Vital Signs, July 10: Stocks Extend Rally into Second Day at Barrons.com
04:54PM  Stock Market Video Analysis For Week Ending 7/10/15
04:00PM  DOW RALLIES 211: Here's what you need to know
02:37PM  ChartAdvisor for July 10 2015 at Investopedia
01:51PM  Is it better to save for retirement or your childs college fund?
02:28AM  Options Hedging Hitting Extreme Levels
Jul-09-15 01:42PM  What the Chinese stock market crash means for the S&P 500
08:36AM  Seeing Ghosts In Negative Data
08:23AM  9 things traders are watching before the market opens
Jul-08-15 06:42PM  Stocks Fall On...
02:00PM  FED: We're worried about Greece
02:17AM  Will Reversal Off 200-Day Moving Average Ignite Stocks?
Jul-07-15 04:32PM  ETF Market Vital Signs, July 7: Buy the Dip. Again. at Barrons.com
03:16PM  Equity ETFs Added Assets in June Despite Market Declines
03:16PM  Equity ETFs Added Asses in June Despite Market Declines
02:26PM  Here's a brief, somewhat disturbing stock market history lesson
02:01PM  S&P 500 Vs. Russell 2000 ETF: Which Should You Get? at Investopedia
Jul-06-15 05:27PM  Greece cancelling Christmas in July
01:44PM  Stocks are lower and crude oil is getting whacked
11:45AM  Chart Advisor for July 3 2015 at Investopedia
08:42AM  Will Greece Affect The Options Market This Week?
Jul-04-15 08:04AM  The Week Ahead: Greece Isn't The Real Problem at Forbes
05:16AM  Greece: What Do Investors Need To Know About Risk?
Jul-03-15 09:41AM  What to expect from the stock market this week
02:06AM  WEEKEND VIDEO: Sentiment, Stocks and more
Jul-02-15 03:37PM  Best And Worst ETFs Of The Week Amid Independence Day Celebration
01:21PM  The single most important element to successful investing
08:30AM  UNEMPLOYMENT RATE DROPS TO 5.3%
08:03AM  Top Five Articles from June: The Rise of Wearables and the End of Capitalism
Jul-01-15 04:17PM  6 Ingredients for 3% GDP - Video Blog
Jun-30-15 08:06PM  VIDEO: 5 Minute Market Recap
06:15PM  ETF Market Quarterly Wrap: The First Half of 2015 is Behind Us at Barrons.com
04:40PM  July 1 most bullish day of year over last 21 years
11:07AM  Pier 1 Imports: Is Its E-Commerce Ship Finally In?
09:32AM  Three Reasons To Stay Patient at Forbes
07:44AM  Here's a quick guide to what traders are talking about this morning
Jun-29-15 06:19PM  Your first trade for Tuesday, June 30 at CNBC
05:39PM  End of Q2 Blues
The investment seeks to track the investment results of an index composed of small-capitalization U.S. equities. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Russell 2000 Index (the "underlying index"), which measures the performance of the small-capitalization sector of the U.S. equity market.
DHR Danaher Corp. daily Stock Chart
DHR [NYSE]
Danaher Corp.
IndexS&P 500 P/E25.31 EPS (ttm)3.63 Insider Own1.50% Shs Outstand683.49M Perf Week3.16%
Market Cap62.79B Forward P/E19.44 EPS next Y4.73 Insider Trans-6.13% Shs Float619.96M Perf Month7.33%
Income2.61B PEG2.20 EPS next Q1.06 Inst Own78.60% Short Float1.99% Perf Quarter12.37%
Sales20.29B P/S3.09 EPS this Y-4.20% Inst Trans0.26% Short Ratio2.83 Perf Half Y9.79%
Book/sh33.97 P/B2.70 EPS next Y11.57% ROA7.20% Target Price98.85 Perf Year24.54%
Cash/sh4.89 P/C18.79 EPS next 5Y11.53% ROE11.00% 52W Range69.82 - 90.99 Perf YTD7.51%
Dividend0.54 P/FCF21.00 EPS past 5Y17.40% ROI9.50% 52W High0.96% Beta1.24
Dividend %0.59% Quick Ratio1.50 Sales past 5Y13.60% Gross Margin52.90% 52W Low31.57% ATR1.19
Employees71000 Current Ratio1.90 Sales Q/Q3.30% Oper. Margin17.00% RSI (14)68.04 Volatility1.78% 1.24%
OptionableYes Debt/Eq0.13 EPS Q/Q2.10% Profit Margin12.90% Rel Volume1.06 Prev Close90.91
ShortableYes LT Debt/Eq0.13 EarningsJul 23 BMO Payout12.70% Avg Volume4.36M Price91.86
Recom1.80 SMA204.71% SMA506.08% SMA2008.96% Volume4,618,352 Change1.04%
Jul-28-15Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-28-15Reiterated Argus Buy $95 → $98
Jul-16-15Initiated RBC Capital Mkts Sector Perform $93
May-22-15Reiterated JP Morgan Overweight $80 → $94
May-18-15Reiterated UBS Buy $100 → $108
May-18-15Reiterated Argus Buy $92 → $95
Jan-28-15Reiterated Stifel Buy $95 → $100
Jan-22-15Initiated UBS Buy $100
Dec-12-14Reiterated Barclays Overweight $86 → $93
Nov-26-14Reiterated FBR Capital Outperform $95 → $100
Nov-21-14Reiterated Argus Buy $86 → $92
Nov-12-14Upgrade FBR Capital Mkt Perform → Outperform $83 → $95
Oct-17-14Reiterated Barclays Overweight $79 → $86
Oct-16-14Reiterated ISI Group Buy $88.50 → $86.50
Sep-17-14Resumed Stifel Buy $90
Apr-09-14Upgrade ISI Group Buy → Strong Buy $86
Dec-31-13Reiterated FBR Capital Mkt Perform $73 → $83
Jul-10-13Reiterated ISI Group Buy $69.50 → $73
Apr-18-13Reiterated ISI Group Buy $70 → $68
Mar-25-13Reiterated Deutsche Bank Hold $64 → $70
Jul-30-15 08:55AM  Align Technology, Inc. Earnings Analysis: By the Numbers
Jul-29-15 09:03AM  Thermo Fisher Scientific, Inc. Earnings Analysis: By the Numbers
Jul-28-15 01:22PM  Morgan Stanley Ups Danaher To Buy On 'Transformational' Pall Deal at Barrons.com
01:04PM  DANAHER CORP /DE/ Financials
10:47AM  EU mergers and takeovers (July 28) Reuters
07:35AM  Morgan Stanley Upgrades Danaher, Says Pall Deal Could Have 'Transformational Impact'
06:21AM  Danaher upgraded by Morgan Stanley
Jul-27-15 02:40PM  New Colfax CEO Matthew Trerotola 'seemed like a very high-potential guy' at bizjournals.com
09:18AM  Illumina, Inc. Earnings Analysis: By the Numbers
Jul-25-15 08:09PM  10-Q for Danaher Corp. at Company Spotlight
Jul-23-15 07:56PM  Danaher (DHR) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
02:05PM  Danaher Tops Q2 Earnings, Revenues on DBS Strength - Analyst Blog
11:10AM  Edited Transcript of DHR earnings conference call or presentation 23-Jul-15 12:00pm GMT
07:28AM  Danaher (DHR) Tops Q2 Earnings, Revenues up Y/Y - Tale of the Tape
07:07AM  Q2 2015 Danaher Corp Earnings Release - 06:00 am ET
06:06AM  Danaher tops Street 2Q forecasts
06:01AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
06:00AM  Danaher Reports Record Second Quarter 2015 Results PR Newswire
Jul-22-15 08:45AM  Senior Marketing, Tech & Finance Executives Join Board of Directors of Symbid, The Funding Network(TM) Marketwired
Jul-21-15 03:00PM  Will Danaher (DHR) Beat Q2 Earnings Estimates this Season? - Analyst Blog
01:50PM  What Awaits Roper Industries (ROP) this Earnings Season? - Analyst Blog
Jul-17-15 05:50PM  NetScout Systems Set to Join the S&P MidCap 400; Tidewater to be Added to S&P SmallCap 600 PR Newswire
Jul-16-15 06:22PM  Danaher Announces Final Proration Factor of 83.2431 percent for Shares Tendered in Split-Off Exchange Offer in Connection with NetScout Transaction PR Newswire
04:38PM  Danaher (DHR) Stock Initiated at RBC Capital at TheStreet
Jul-15-15 03:17PM  Has Delivering Alpha Delivered So Far?
12:10PM  NetScout Systems (NTCT) Stock Continues Gaining After Closing Acquisition at TheStreet
11:28AM  US Business Inventories Rise: Business Outlook Positive
Jul-14-15 08:50AM  Danaher Announces Preliminary Results of Split-Off Exchange Offer in Connection with NetScout Transaction; Completes Merger PR Newswire
Jul-10-15 05:22PM  DANAHER CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obli
12:39PM  A Great Deal Between Danaher and Pall Corporation
Jul-09-15 05:06PM  Danaher Sets Final Exchange Ratio in Split-Off Exchange Offer and Announces Automatic Extension of Exchange Offer to Midnight on July 13, 2015 in Connection with NetScout Transaction PR Newswire
Jul-08-15 05:16PM  DANAHER CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
08:00AM  Upcoming Spin-Offs Worth Investing In at Kiplinger
Jul-05-15 10:33AM  5 Trade Ideas for Monday: CBOE, Danaher, Dunkin Brands, St. Joe & Qlik
Jul-02-15 12:58PM  Disruptive diagnostics firm Theranos gets boost from FDA at Fortune
10:50AM  Danaher Prices Senior Notes to Partly Fund Pall Buyout - Analyst Blog
07:21AM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jul-01-15 11:21PM  DH Europe Finance S.A -- Moody's assigns A2 rating to new notes of DH Europe Finance S.A. at Moody's
09:40PM  Danaher Announces Pricing of Euro-Denominated Senior Notes Offering PR Newswire
02:24PM  These stocks win in 2nd half
Jun-30-15 04:32PM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events
10:24AM  Trian's Garden: Great value in Pentair
Jun-29-15 12:00PM  Activist investors love spin-offs. Heres why you should, too at Fortune
11:18AM  Five Dividend Stocks With Goliath Potential at Forbes
Jun-25-15 04:46PM  Danaher Corporation Announces Amendment and Extension by One Day of Split-Off Exchange Offer in Connection with NetScout Transaction PR Newswire
04:00PM  Danaher Schedules Second Quarter 2015 Earnings Conference Call PR Newswire
Jun-22-15 04:41PM  MediaBeacon Joining Henry Stewart DAM EU Conference Marketwired
Jun-16-15 08:00AM  Pall Announces Record Date for Special Meeting of Shareholders to Vote on Merger Agreement with Danaher Business Wire
Jun-15-15 07:45AM  Are investors still safe in ignoring Greece?
Jun-13-15 06:26AM  Edited Transcript of DHR corporate analyst meeting
Jun-12-15 02:04PM  Danaher: Buy, Buy Buy at Barrons.com
08:55AM  Top Analyst Upgrades and Downgrades: Citrix, Danaher, Host Hotels, Keurig, Micron and More at 24/7 Wall St.
Jun-03-15 02:07PM  Rising rate stock picks
Jun-02-15 07:00AM  Ultimate Stock-Pickers: Top 10 Buys and Sells at Morningstar
May-29-15 09:41AM  Faber Report: M&A getting frothy?
May-28-15 05:00PM  Danaher to Present at Deutsche Bank Global Industrials and Basic Materials Conference PR Newswire
May-22-15 12:06PM  What Is the Expected Timing of the PallDanaher Transaction?
12:06PM  Danaher Intends to Split Up Next Year
11:53AM  Danaher is 'Looking Brilliant' After Pall's Big Beat at Barrons.com
May-21-15 03:57PM  Pall-Danaher Transaction: What You Should Know about Danaher
03:57PM  Pall-Danaher Transaction: An Overview of Pall
11:45AM  PALL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Pall Corporation Over the Proposed Sale of the Company to Danaher Corporation - PLL PR Newswire
11:42AM  Basics of the PallDanaher Transaction
11:41AM  The PallDanaher Spread is Trading Like a Safe Deal
May-20-15 04:19PM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-19-15 06:01PM  Yahoo Stock Dives On Feared IRS Spinoff Rule Changes at Investor's Business Daily
05:00PM  Yahoo tanks on IRS spinoff scare
12:01PM  What Makes Danaher Corp. Such a Star?
07:00AM  Ultimate Stock-Pickers Top 10 High-Conviction and New-Money Purchases at Morningstar
06:02AM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-18-15 04:00PM  Danaher Announces Quarterly Dividend PR Newswire
May-15-15 04:11PM  PALL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pall Corporation PR Newswire
11:30AM  Danaher-NetScout Deal: Initiates Shares Exchange Offer - Analyst Blog
07:09AM  Danahers Industrial Blueprint for Business Growth at Bloomberg
05:09AM  U.S. dealmaking climbs 48 percent to highest levels since 2007
May-14-15 02:53PM  Deutsche Bank: Danaher Deal May Fail To Meet Goals
01:31PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Pall Corporation of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to Danaher Corporation -- PLL PR Newswire
11:40AM  Danaher to Buy Pall for $14B; Plans to Split Itself - Analyst Blog
11:33AM  Danaher: Going to $100? at Barrons.com
08:12AM  Guilty Banks and Complaining Spoofers
08:00AM  Danaher Commences Split-Off Exchange Offer For Its Communications Business In Connection With NetScout Transaction PR Newswire
07:27AM  'Now-or-never' fear drives corporate deal boom
06:00AM  Jim Cramer: Companies Play a Big Role in Pushing Their Stocks Higher at TheStreet
12:39AM  [$$] Danaher to Split Up Businesses, Buy Pall for $13.6 Billion at The Wall Street Journal
May-13-15 07:20PM  Danaher to Buy Pall, Split Up Businesses at The Wall Street Journal
06:48PM  Danaher To Buy Pall For $13.8 Billion, Split In 2
06:48PM  Danaher Acquiring Pall, Splitting Off Industrial Biz at Investor's Business Daily
06:13PM  Listen up! Cramer calls for bold CEO action at CNBC
06:00PM  Cramer: Don't just stand there, do something!
05:59PM  McKesson, Other Top Stocks Fade After Hitting New Highs at Investor's Business Daily
04:14PM  DANAHER CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements
04:13PM  Robbins Arroyo LLP: Acquisition of Pall Corporation (PLL) by Danaher Corporation (DHR) May Not Be in Shareholders' Best Interests PR Newswire
04:09PM  Stocks Little Changed as Investors Weigh Good and Bad of Weak Retail Data at TheStreet
03:54PM  Pall Corporation -- Moody's changes outlook on Danaher to negative on Pall Corp acquisition; affirms A2, P-1 ratings at Moody's
02:56PM  Stocks Are Flat as Retail Data Disappoints, DuPont Drags at TheStreet
02:21PM  Danaher Breakup And The New Corporate Activism, With Or Without Wall Street at Forbes
02:16PM  Billionaire Rales Brothers Revamp Danaher Empire As Part Of $13.8 Billion Pall Deal at Forbes
01:21PM  4 Big Stocks Getting Big Attention -- and How to Trade Them at TheStreet
01:08PM  Danaher Holders Finally Get What Theyve Waited For: Real M&A at Bloomberg
11:48AM  Danaher Grabs Pall for $13.8B and Plans to Split Merged Company at TheStreet
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; hardware and software solutions to deploy, manage, and secure communication network technologies and services; and tools, toolboxes, and automotive maintenance equipment. Its Environmental segment offers instrumentation and disinfection systems to analyze and manage the quality of water; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale systems, payment systems, environmental compliance, vehicle tracking, and fleet management. The company's Life Sciences & Diagnostics segment provides various research tools for scientists to study cells and cell components; and various analytical instruments, reagents, consumables, software, and services for hospitals, physician's offices, reference laboratories, and other critical care settings. Its Dental segment provides various dental consumables, equipment, and services for the diagnosis, treatment, and prevention of disease and ailments of the teeth, gums, and supporting bone. The company's Industrial Technologies segment offers equipment, consumables, and software for consumer and industrial products; and mechanical and electromechanical motion control solutions for the automation market. It also provides sensors and control instruments to manufacturing markets and electric utility industry; energetic material systems to systems integrators and prime contractors; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHWIETERS JOHN TDirectorJul 28Option Exercise28.168,000225,28021,507Jul 29 06:42 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerJul 28Sale88.116,480570,97216,092Jul 29 06:42 PM
Beck Mark AExecutive Vice PresidentJul 28Sale87.746,890604,5080Jul 29 06:41 PM
COMAS DANIEL LEVP & CFOJul 27Option Exercise37.0765,0002,409,550164,798Jul 28 05:24 PM
LICO JAMES AExecutive Vice PresidentJul 27Sale87.2017,9701,566,912114,065Jul 28 05:26 PM
COMAS DANIEL LEVP & CFOJul 27Sale87.5965,0005,693,22099,798Jul 28 05:24 PM
Joyce Thomas Patrick JRPresident and CEOJul 24Option Exercise37.0725,300937,871141,123Jul 27 06:16 PM
DANIEL WILLIAM KEVPJul 24Sale88.4015,0001,326,06097,950Jul 27 06:17 PM
Joyce Thomas Patrick JRPresident and CEOJul 24Sale88.2025,3002,231,389115,823Jul 27 06:16 PM
Lalor Angela SSVP, Human ResourcesMay 28Sale87.065,959518,81435,851May 29 07:47 AM
LOHR WALTER GDirectorMay 22Option Exercise28.168,000225,280460,635May 26 04:50 PM
LOHR WALTER GDirectorMay 22Sale87.008,000696,000452,635May 26 04:50 PM
Graham Jonathan PSenior VP & GCMay 19Option Exercise50.8237,7321,917,52264,838May 20 05:22 PM
Graham Jonathan PSenior VP & GCMay 19Sale86.8930,2322,626,85034,606May 20 05:22 PM
Graham Jonathan PSenior VP & GCMay 15Option Exercise37.1349,7551,847,37168,026May 18 05:17 PM
Graham Jonathan PSenior VP & GCMay 15Sale87.0049,7554,328,88927,106May 18 05:17 PM
Graham Jonathan PSenior VP & GCMay 14Option Exercise32.69135,8654,441,851162,971May 18 05:17 PM
Graham Jonathan PSenior VP & GCMay 14Sale88.00135,86511,956,12027,106May 18 05:17 PM
COMAS DANIEL LEVP & CFOApr 24Option Exercise25.8525,000646,250124,798Apr 27 05:20 PM
Joyce Thomas Patrick JRPresident and CEOApr 24Option Exercise37.0725,300937,871159,768Apr 27 05:20 PM
DANIEL WILLIAM KEVPApr 24Option Exercise34.7058,4002,026,588142,950Apr 27 05:20 PM
Joyce Thomas Patrick JRPresident and CEOApr 24Sale83.8143,9453,683,076115,823Apr 27 05:20 PM
DANIEL WILLIAM KEVPApr 24Sale83.3358,4004,866,313112,950Apr 27 05:20 PM
COMAS DANIEL LEVP & CFOApr 24Sale83.5025,0002,087,38699,798Apr 27 05:20 PM
Raskas DanielSVP-Corporate DevelopmentFeb 26Sale87.794,179366,86216,662Feb 27 05:30 PM
Graham Jonathan PSenior VP & GCFeb 24Sale86.779,961864,33627,106Feb 25 08:04 PM
Raskas DanielSVP-Corporate DevelopmentFeb 20Option Exercise30.7356,0001,720,88081,808Feb 23 05:07 PM
Raskas DanielSVP-Corporate DevelopmentFeb 20Sale87.0356,0004,873,90425,808Feb 23 05:07 PM
EHRLICH DONALD JDirectorFeb 03Option Exercise28.168,000225,28095,635Feb 04 05:05 PM
EHRLICH DONALD JDirectorFeb 03Sale84.828,000678,56087,635Feb 04 05:05 PM
LICO JAMES AExecutive Vice PresidentFeb 02Option Exercise30.7398,0003,011,540246,606Feb 03 05:47 PM
LICO JAMES AExecutive Vice PresidentFeb 02Sale82.6498,0008,099,070148,606Feb 03 05:47 PM
COMAS DANIEL LEVP & CFOJan 28Option Exercise25.8575,0001,938,750193,695Jan 29 05:46 PM
COMAS DANIEL LEVP & CFOJan 28Sale84.5975,0006,344,503118,695Jan 29 05:46 PM
DITKOFF JAMES HSenior VP-Finance & TaxNov 20Sale82.353,606296,954172,948Nov 21 04:26 PM
LICO JAMES AExecutive Vice PresidentOct 31Sale80.3925,2382,028,885103,451Nov 04 05:58 PM
Graham Jonathan PSenior VP & GCOct 30Option Exercise37.0720,000741,40063,969Nov 03 05:18 PM
Graham Jonathan PSenior VP & GCOct 30Sale79.2720,0001,585,50043,969Nov 03 05:18 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 20Option Exercise30.7340,0001,229,20065,808Oct 21 05:05 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 20Sale74.6540,0002,986,12025,808Oct 21 05:05 PM
COMAS DANIEL LEVP & CFOOct 17Option Exercise25.8550,0001,292,500168,695Oct 21 05:04 PM
COMAS DANIEL LEVP & CFOOct 17Sale75.1050,0003,755,075118,695Oct 21 05:04 PM
LOHR WALTER GDirectorSep 04Option Exercise26.188,000209,440460,635Sep 04 06:31 PM
King WilliamSenior Vice PresidentAug 01Sale73.743,545261,40824,329Aug 04 07:38 AM
WY Weyerhaeuser Co. daily Stock Chart
WY [NYSE]
Weyerhaeuser Co.
IndexS&P 500 P/E23.98 EPS (ttm)1.27 Insider Own0.10% Shs Outstand517.75M Perf Week1.43%
Market Cap15.77B Forward P/E18.92 EPS next Y1.61 Insider Trans-9.06% Shs Float510.46M Perf Month-3.30%
Income701.00M PEG4.80 EPS next Q0.20 Inst Own83.80% Short Float1.84% Perf Quarter-2.46%
Sales7.39B P/S2.13 EPS this Y70.70% Inst Trans-0.11% Short Ratio2.59 Perf Half Y-12.48%
Book/sh9.58 P/B3.18 EPS next Y48.39% ROA12.10% Target Price36.14 Perf Year-0.93%
Cash/sh2.24 P/C13.62 EPS next 5Y5.00% ROE29.10% 52W Range29.63 - 36.41 Perf YTD-13.65%
Dividend1.16 P/FCF309.23 EPS past 5Y28.50% ROI10.60% 52W High-16.33% Beta1.21
Dividend %3.81% Quick Ratio2.40 Sales past 5Y7.90% Gross Margin21.70% 52W Low2.80% ATR0.44
Employees12800 Current Ratio3.10 Sales Q/Q-0.90% Oper. Margin17.50% RSI (14)41.96 Volatility1.32% 1.46%
OptionableYes Debt/Eq1.08 EPS Q/Q-41.40% Profit Margin22.90% Rel Volume0.90 Prev Close30.30
ShortableYes LT Debt/Eq1.08 EarningsJul 31 BMO Payout34.70% Avg Volume3.63M Price30.46
Recom2.20 SMA20-1.49% SMA50-3.81% SMA200-8.28% Volume3,255,692 Change0.53%
Jul-16-15Downgrade BofA/Merrill Buy → Neutral
Jun-17-15Initiated Dundee Neutral $34
May-04-15Reiterated UBS Sell $29 → $27
Feb-17-15Reiterated Argus Buy $39 → $43
Nov-03-14Reiterated DA Davidson Buy $37 → $40
Aug-18-14Reiterated Argus Buy $36 → $39
Aug-04-14Upgrade DA Davidson Neutral → Buy $33 → $37
Apr-29-13Reiterated UBS Sell $20 → $24
Jan-29-13Reiterated Argus Buy $33 → $36
Jan-28-13Downgrade RBC Capital Mkts Outperform → Sector Perform $30 → $31
Jan-16-13Reiterated BMO Capital Markets Market Perform $28.50 → $33
Jul-17-12Downgrade BMO Capital Markets Market Perform → Underperform
Jul-06-12Downgrade DA Davidson Buy → Neutral $27 → $23
Mar-05-12Upgrade BMO Capital Markets Underperform → Market Perform $33 → $36
Feb-06-12Reiterated BMO Capital Markets Underperform $16 → $20
Oct-31-11Upgrade Deutsche Bank Sell → Hold $19 → $19
Aug-12-11Upgrade RBC Capital Mkts Underperform → Sector Perform $18 → $18
Aug-10-11Upgrade UBS Sell → Neutral
Aug-05-11Upgrade DA Davidson Neutral → Buy $22 → $22
Aug-01-11Reiterated Barclays Capital Overweight $33 → $31
Jul-30-15 07:22PM  August may mean big things for markets and the Fed at CNBC
Jul-29-15 01:20PM  Will Weyerhaeuser Company's (WY) Q2 Earnings Surprise? - Analyst Blog
Jul-16-15 08:14AM  Analysts' Actions -- GM, Google, Intel and More
07:59AM  Weyerhaeuser downgraded by BofA/Merrill
Jul-02-15 05:33PM  Martin Whitman Buys Three New Stakes
03:05PM  Weyerhaeuser's Investment Value Weakens on Dicey Future - Analyst Blog
12:30PM  Weyerhaeuser closes Oregon tree farms to public access due to high forest fire danger PR Newswire
Jul-01-15 04:30PM  Weyerhaeuser to Release Second Quarter Results on July 31 PR Newswire
Jun-26-15 06:19PM  EXCLUSIVE: REI outgrows Kent space, considers options for new HQ at bizjournals.com
Jun-24-15 06:29PM  Steve O'Connor, head of UW's Runstad Center, steps down at bizjournals.com
06:55AM  Why Alibaba and Best Buy set up shop in Washington at CNBC
Jun-16-15 10:00AM  Weyerhaeuser Distribution Promotes David Helmers to Vice President Business Wire
Jun-15-15 10:21AM  Standard Pacific-Ryland: a rare home builder merger at CNBC
May-26-15 06:31PM  Simons to represent Weyerhaeuser at REITWeek: NAREIT's Investor Forum PR Newswire
12:33PM  Notable option activity in equities
06:01AM  WEYERHAEUSER CO Files SEC form 8-K/A, Change in Directors or Principal Officers
May-22-15 05:26PM  Weyerhaeuser Company Declares Dividend on Common Shares PR Newswire
May-20-15 03:14PM  Gov't agency 'aware of issues' in GDP data
May-15-15 06:00AM  The 10 stocks likely to drop this summer: Goldman at CNBC
May-12-15 09:21AM  Cramer's Mad Dash: RAX & RDS.a
May-09-15 12:01AM  Can Third Avenue Get Back On Track? at Barrons.com
May-03-15 08:13PM  10-Q for Weyerhaeuser Co. at Company Spotlight
May-01-15 04:50PM  Weyerhaeuser (WY) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
10:07AM  Weyerhaeuser Misses Q1 Earnings and Revenues, Down Y/Y - Analyst Blog
08:15AM  Polcari: The Kiss Of Death, Weak GDP and the Iran Effect at Investor's Business Daily
07:53AM  Early movers: NWL, MCO, VFC, CVS, LNKD & more at CNBC
07:37AM  Weyerhaeuser's Profit Falls at The Wall Street Journal
07:07AM  Q1 2015 Weyerhaeuser Co Earnings Release - Before Market Open
06:03AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:03AM  Weyerhaeuser misses Street 1Q forecasts
04:22AM  Weyerhaeuser (WY) Q1 Earnings and Revenues Lag Estimates - Tale of the Tape
03:05AM  Weyerhaeuser Reports First Quarter Results PR Newswire
Apr-30-15 07:12PM  Stocks entering May with low expectations at CNBC
10:15AM  Moving Average Crossover Alert: Weyerhaeuser (WY) - Tale of the Tape
Apr-29-15 05:58PM  Will Weyerhaeuser (WY) Miss Q1 Earnings on Market Woes? - Analyst Blog
Apr-14-15 01:44PM  Weyerhaeuser Company -- Moody's upgrades Weyerhaeuser to Baa2 at Moody's
Apr-03-15 07:00PM  Weyerhaeuser to Release First Quarter Results on May 1 at noodls
06:35PM  Weyerhaeuser to Release First Quarter Results on May 1 PR Newswire
Mar-19-15 11:00AM  Watch Out Below For Falling Lumber Prices at Investopedia
Mar-15-15 10:44AM  5 Trade Ideas for Monday: Cigna, Hain Celestial, Old Dominion Freight Line, PerkinElmer & Weyerhaeuser
Mar-12-15 11:55AM  Work underway on Weyerhaeuser's glassy new Seattle headquarters at bizjournals.com
Feb-20-15 05:00PM  Simons, Bedient to Represent Weyerhaeuser at Upcoming Investor Conferences PR Newswire
01:04PM  WEYERHAEUSER CO Financials
Feb-17-15 10:28AM  Weyerhaeuser Gains on Housing Market Revival, Runs Risks - Analyst Blog
Feb-15-15 07:07PM  10-K for Weyerhaeuser Co. at Company Spotlight
Feb-13-15 04:19PM  Weyerhaeuser Company Declares Dividend on Common Shares at noodls
04:15PM  Weyerhaeuser Company Declares Dividend on Common Shares PR Newswire
Feb-11-15 07:00AM  Weyerhaeuser Company (WY): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
Feb-06-15 03:20PM  How a West Coast port closure would hurt the economy at MarketWatch
Feb-02-15 01:11PM  The Reincarnation of Bell Labs at Fortune
10:10AM  Company News for February 02, 2015 - Corporate Summary
Jan-30-15 04:25PM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial St EDGAR Online
04:10PM  Weyerhaeuser Announces Election of David Bozeman to Board of Directors PR Newswire
02:46PM  Weyerhaeuser (WY) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
12:40PM  Weyerhaeuser Q4 Earnings and Revenues Miss Estimates - Analyst Blog Zacks
07:57AM  Early movers: YHOO, FL, TYC, XRX, TSN & more at CNBC
07:07AM  Q4 2014 Weyerhaeuser Co Earnings Release - Before Market Open CCBN
05:10AM  Weyerhaeuser misses Street 4Q forecasts AP
04:54AM  Weyerhaeuser (WY) Q4 Earnings and Revenues Lag Estimates - Tale of the Tape Zacks
03:05AM  Weyerhaeuser Reports Fourth Quarter, Full Year Results PR Newswire
Jan-29-15 02:46PM  What to Expect When Weyerhaeuser (WY) Reports Fourth-Quarter Earnings Tomorrow at TheStreet
08:58AM  Why Earnings Season Could Be Great for Weyerhaeuser (WY) - Tale of the Tape Zacks
Jan-28-15 08:04PM  Farallon Capital sells stake in Weyerhaeuser Co. Market Realist
02:00PM  Can Weyerhaeuser Beat Q4 Earnings on Housing Recovery? - Analyst Blog Zacks
06:05AM  Up to Speed: Peltz receives ammo in fight against DuPont (Video) at American City Business Journals
Jan-20-15 12:45PM  ETF Securities Branches out From Commodities ETFs ETF Trends
11:10AM  Will United Rentals (URI) Miss Earnings Estimates in Q4? - Analyst Blog Zacks
Jan-13-15 06:29PM  Washington's employers may soon face a legion of allied unions at American City Business Journals
01:22PM  Weyerhaeuser Announces Tax Treatment of 2014 Distributions PR Newswire
Jan-08-15 06:15PM  Weyerhauser to cut jobs in response to port slowdown at American City Business Journals
Dec-29-14 01:01PM  Weyerhaeuser to release fourth quarter earnings on Jan. 30 PR Newswire
Dec-22-14 04:56PM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online
Dec-21-14 08:30AM  5 Trade Ideas for Monday: Domino's, Conagra, Schlumberger, AmerisourceBergen & Weyerhaeuser Yahoo Finance Blogs
Dec-19-14 11:39AM  Farallon Capital starts new position in International Game Technology Market Realist
Nov-20-14 02:44PM  Wynn Resorts Probed on Money-Laundering Controls The Wall Street Journal
Nov-14-14 04:50PM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online
04:30PM  Weyerhaeuser Announces Leadership Changes for Cellulose Fibers, Wood Products PR Newswire
Nov-12-14 04:59PM  Get Ideas For Stock Buys, Sells In Mutual Fund Monthly Reports Investor's Business Daily
Nov-04-14 06:38PM  Boise Cascade Building Profit Ahead Of New-Home Cycle at Investor's Business Daily
Nov-03-14 07:08PM  10-Q for Weyerhaeuser Co. Company Spotlight
12:07PM  3 Materials & Construction Stocks Moving The Industry Upward at TheStreet
Oct-31-14 08:28PM  Weyerhaeuser (WY) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
10:47AM  [video]Weyerhaeuser Earnings Beat Wall Street Estimates on Timber at TheStreet
10:40AM  Weyerhaeuser Beats on Q3 Earnings, Posts Weak Outlook Zacks
07:50AM  Weyerhaeuser Profit Rises, Outlook Appears Soft at 24/7 Wall St.
07:07AM  Q3 2014 Weyerhaeuser Co Earnings Release - Before Market Open CCBN
06:01AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
05:03AM  Weyerhaeuser beats Street 3Q forecasts AP
03:38AM  Weyerhaeuser reports higher third-quarter profit Reuters
03:05AM  Weyerhaeuser Reports Third Quarter Results PR Newswire
Oct-29-14 06:30PM  Will Weyerhaeuser (WY) Miss Earnings Estimates in Q3? Zacks
Oct-15-14 08:14PM  Weyerhaeuser Company Declares Dividend PR Newswire
Oct-14-14 09:45AM  Weyerhaeuser, Elizabeth Arden, Eni, SAP and Sanofi highlighted as Zacks Bull and Bear of the Day Zacks
01:00AM  Bull of the Day: Weyerhaeuser (WY) Zacks
Oct-06-14 01:03PM  3 Real Estate Stocks Dragging The Industry Down at TheStreet
Sep-25-14 02:35PM  Weyerhaeuser to release third quarter results on Oct. 31 PR Newswire
Sep-24-14 01:03PM  3 Stocks Boosting The Real Estate Industry Higher at TheStreet
Sep-19-14 05:16AM  Show of support for Weyerhaeuser optionMONSTER
12:29AM  Marty Whitman's Third Avenue Buys 2 Forest Products Companies Gurufocus
Sep-12-14 01:04PM  3 Stocks Dragging The Financial Sector Downward at TheStreet
Weyerhaeuser Co. is a real estate investment trust. It primarily invests in United States. The firm operates under four business segments, timberlands, wood products, cellulose fibers and real estate. It owns timberlands primarily in the U.S and has long-term licenses in Canada. The firm manufactures wood and specialty cellulose fibers products, and develops real estate, primarily as a builder of single-family homes. Weyerhaeuser Co was founded in 1900 and is based in Federal Way, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Merle Denise MSenior Vice PresidentFeb 04Option Exercise23.2911,559269,26027,743Feb 05 05:27 PM
Hunter Rhonda DSr. Vice PresidentFeb 04Option Exercise21.198,441178,84337,029Feb 05 05:27 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 04Option Exercise26.7131,587843,83568,372Feb 05 05:35 PM
Hunter Rhonda DSr. Vice PresidentFeb 04Sale35.268,441297,63428,588Feb 05 05:27 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 04Sale35.2631,5871,113,77336,785Feb 05 05:35 PM
Merle Denise MSenior Vice PresidentFeb 04Sale35.4211,559409,47116,184Feb 05 05:27 PM
Bedient Patricia MExecutive Vice President & CFONov 10Option Exercise23.9215,017359,237173,729Nov 12 12:16 PM
Bedient Patricia MExecutive Vice President & CFONov 10Sale34.5015,017518,087158,712Nov 12 12:16 PM
Bedient Patricia MExecutive Vice President & CFONov 05Option Exercise23.9214,182339,262172,894Nov 06 07:46 PM
Bedient Patricia MExecutive Vice President & CFONov 05Sale34.5014,182489,280158,712Nov 06 07:46 PM
Hunter Rhonda DSr. Vice PresidentAug 27Option Exercise14.8012,242181,21840,266Aug 28 07:33 PM
Hunter Rhonda DSr. Vice PresidentAug 27Sale34.2112,242418,77628,024Aug 28 07:33 PM
CELG Celgene Corporation daily Stock Chart
CELG [NASD]
Celgene Corporation
IndexS&P 500 P/E49.95 EPS (ttm)2.64 Insider Own0.20% Shs Outstand793.14M Perf Week-5.13%
Market Cap104.60B Forward P/E21.90 EPS next Y6.02 Insider Trans-16.55% Shs Float789.13M Perf Month13.95%
Income2.20B PEG2.01 EPS next Q1.20 Inst Own82.90% Short Float1.80% Perf Quarter22.04%
Sales8.43B P/S12.41 EPS this Y42.30% Inst Trans0.14% Short Ratio2.98 Perf Half Y9.11%
Book/sh8.53 P/B15.46 EPS next Y25.86% ROA13.20% Target Price151.39 Perf Year49.29%
Cash/sh9.22 P/C14.30 EPS next 5Y24.88% ROE36.80% 52W Range83.16 - 140.72 Perf YTD17.90%
Dividend- P/FCF- EPS past 5Y23.60% ROI16.30% 52W High-6.28% Beta0.98
Dividend %- Quick Ratio4.40 Sales past 5Y23.30% Gross Margin95.20% 52W Low58.59% ATR3.53
Employees6012 Current Ratio4.60 Sales Q/Q21.60% Oper. Margin32.10% RSI (14)58.73 Volatility2.68% 2.32%
OptionableYes Debt/Eq1.01 EPS Q/Q-40.30% Profit Margin26.10% Rel Volume1.05 Prev Close132.14
ShortableYes LT Debt/Eq0.93 EarningsJul 23 BMO Payout0.00% Avg Volume4.78M Price131.88
Recom1.90 SMA203.21% SMA509.96% SMA20014.43% Volume5,038,704 Change-0.20%
Jul-24-15Reiterated UBS Buy $142 → $156
Jul-24-15Reiterated JMP Securities Mkt Outperform $133 → $147
Jul-24-15Reiterated Cantor Fitzgerald Buy $146 → $163
Jul-21-15Reiterated Piper Jaffray Overweight $144 → $160
Jul-15-15Reiterated RBC Capital Mkts Outperform $135 → $150
Jul-15-15Reiterated Barclays Equal Weight $120 → $130
Feb-25-15Reiterated Argus Buy $130 → $155
Dec-09-14Reiterated UBS Buy $112 → $130
Dec-09-14Reiterated Argus Buy $102 → $130
Oct-24-14Reiterated Deutsche Bank Buy $115 → $134
Sep-29-14Reiterated RBC Capital Mkts Outperform $100 → $115
Aug-06-14Reiterated RBC Capital Mkts Outperform $95 → $100
Apr-25-14Reiterated Summer Street Research Buy $205 → $184
Mar-19-14Reiterated Summer Street Research Buy $180 → $205
Feb-27-14Reiterated UBS Buy $200 → $209
Jan-28-14Reiterated Deutsche Bank Buy $170 → $190
Jan-14-14Reiterated Brean Capital Buy $191 → $233
Dec-05-13Upgrade UBS Neutral → Buy $163 → $200
Oct-28-13Reiterated Argus Buy $175
Oct-25-13Reiterated Barclays Overweight $158 → $173
Jul-30-15 08:09PM  10-Q for Celgene Corp. at Company Spotlight
01:33PM  Celgene is pushed into paying a high price for Receptos at Financial Times
09:07AM  Large-Cap Healthcare Stocks Outperform Small Caps
08:53AM  Celgene Corp. Earnings Analysis: By the Numbers
Jul-29-15 04:01PM  Celgene says patent-fighting hedge fund manager wants to short its shares Reuters
03:15PM  Drugmakers Strike Back: Kyle Bass Blasted Over Patent Challenges at Bloomberg
03:15PM  Drugmakers Strike Back: Kyle Bass Blasted Over Patent Challenges
02:47PM  Q2 Earnings Season Halftime Report
11:24AM  Healthcare and Biotech Stocks Accelerate Their Longer-Term Trends
11:02AM  Four Reasons Gilead Can Head Higher at Barrons.com
09:41AM  Amp Up Your Portfolio With These Biotech Stocks at Motley Fool
09:03AM  Bristol-Myers Squibb Co. Earnings Analysis: By the Numbers
Jul-28-15 04:55PM  Move over Juno: This company just had the largest biotech IPO ever at bizjournals.com
01:18PM  Is More M&A On The Way For Large-Cap Biotechs?
12:57PM  Under the radar names you're missing
12:08PM  NantKwest Surges As Biggest Biotech Market Cap IPO at Investor's Business Daily
10:35AM  Biogens 2Q15 Earnings Beat Wall Street Estimates
10:02AM  Wait, Will Allergan Really Buy Biogen or Amgen? at Barrons.com
07:30AM  Celgene Corporation Commences Tender Offer for Receptos, Inc. Business Wire
07:03AM  3 Big Biotech Buybacks That Investors Should Love at Motley Fool
06:04AM  CELGENE CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jul-27-15 05:22PM  Teva Tags Allergan's Generics: $40.5 Bil
02:37PM  Gilead Earnings Preview and The Moment of Truth
12:24PM  Morgan Stanley Raises Price Target On Celgene, Still Highlights Several Risks
11:45AM  Biogen: Buy the Stock Get the Pipeline for Free at Barrons.com
09:52AM  Cramer's Stop Trading: Biogen & GrubHub
09:32AM  Week Ahead: 10 IPOs Set To Price During The Week Of July 27 at Insider Monkey
07:57AM  Short Sellers Back Off Major Biotechs at 24/7 Wall St.
Jul-25-15 07:07AM  1 ETF Thats Crushing Even Warren Buffett at Motley Fool
Jul-24-15 06:33PM  Biotech IPO Boom Gaining Thrust With NantKwest Debut at Investor's Business Daily
06:25PM  Who's leading the pack?
02:09PM  Biogen: Run Lola Run? at Barrons.com
01:20PM  Biogen's Big-Volume Plunge Marks End Of 5-Year Run
10:10AM  Celgene Delivers as Expected in Q2, but Raises New Questions at Motley Fool
09:24AM  Cramer's Mad Dash: Biogen's biotech blues
08:08AM  'Nifty' growth stocks keep the bears at bay, for now
Jul-23-15 04:33PM  Dow Drops 119 Points at Barrons.com
02:16PM  Silver Arrows Top Long Positions: Facebook Inc (FB), Celgene Corporation (CELG), Hertz Global Holdings Inc (HTZ), More at Insider Monkey
02:11PM  Celgene (CELG) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
01:26PM  Celgene Q2 Earnings & Revenues In Line, Keeps View - Analyst Blog
01:04PM  Celgene's Q2 Earnings Call: Highlights & Analyst Commentary
12:56PM  Celgene's Adjusted Profit Rises on Revlimid Sales at The Wall Street Journal
12:54PM  Celgene Rolling Along (But You Already Knew That) at Motley Fool
12:17PM  Health care on a hot streak
12:05PM  Edited Transcript of CELG earnings conference call or presentation 23-Jul-15 1:00pm GMT
11:52AM  Celgene Hikes Outlook: But What About the Receptos Dilution? at Barrons.com
09:50AM  Celgene Earnings Beat and Updated Guidance
09:37AM  Valeant Earnings Soar On M&A, Organic Sales Growth at Investor's Business Daily
09:25AM  Celgene (CELG) Reports In Line Q2 Earnings and Revenues - Tale of the Tape
08:06AM  Celgene beats Street 2Q forecasts
07:41AM  CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:30AM  Celgene Reports Second Quarter 2015 Operating and Financial Results Business Wire
07:07AM  Q2 2015 Celgene Corp Earnings Release - Before Market Open
Jul-22-15 08:04PM  Biotech ETFs: 3 Questions For IShares Investing Expert at Investor's Business Daily
07:01PM  Why Earnings Season Should Matter To ETF Investors at Investor's Business Daily
06:35PM  Brace yourself! Thursday is earnings palooza at CNBC
06:00PM  Cramer: All comes back to China
04:50PM  Illumina Breaches Key Level On Q2 Sales Miss
04:25PM  A look at Juno's stock nearly a month after its historic deal with Celgene at bizjournals.com
02:19PM  Evercore ISI's Schoenebaum Breaks Down Celgene-Receptos Merger
11:56AM  Here Are The Companies Reporting Earnings Over The Next 48 Hours
10:16AM  New 'trolls' are crushing innovation in biopharma at CNBC
09:01AM  5 Reasons Celgene Corporation Is a Buy at Motley Fool
Jul-21-15 02:00PM  What's in Store for Celgene (CELG) This Earnings Season? - Analyst Blog
12:24PM  Why This Analyst Expects New Alzhemiers Trials Could Produce the Most Important Drugs in History
12:17PM  Yes, Celgene is Still a Top Large Cap Pick at Barrons.com
12:13PM  Options Update: How to Play Celgene
07:03AM  3 Questions Investors Should Ask When Celgene Reports Its Second-Quarter Results at Motley Fool
06:00AM  Jim Cramer's Top Takeaways: Celgene, Facebook, Amazon.com, Netflix, Google at TheStreet
Jul-20-15 08:05PM  Stock Market Today - 07/17/15
07:06PM  Cramer Remix: When to take a bite out of Apple at CNBC
07:00PM  Cramer: When to take a bite out of Apple
06:50PM  Earnings Loom For Handful Of Top Big Cap 20 Stocks at Investor's Business Daily
06:25PM  JNJ could unlock 50% more value: Cramer
06:00PM  Cramer: This week is a minefield
04:58PM  What to Expect from Biogen and Celgene at Barrons.com
09:35AM  Top Health Care Earnings for the Week Ahead at 24/7 Wall St.
Jul-19-15 01:17PM  Is Celgene Brilliant or Downright Crazy? at Motley Fool
Jul-18-15 01:10AM  Biotech: The Forgotten Bubble at Barrons.com
Jul-17-15 06:48PM  Newfound Market Strength Could Benefit These IBD 50 Names at Investor's Business Daily
05:28PM  CELGENE CORP /DE/ Files SEC form 8-K, Other Events
12:58PM  Betting against biotech has been a fools errand at MarketWatch
11:22AM  Cautionary tale as Receptos benefits from buying frenzy at Financial Times
10:49AM  Why Big Biotech Could Have Another Leg Up
Jul-16-15 06:00PM  Cramer: Don't give up on these stocks
05:43PM  Biotech plays ahead of Alzheimer's conference
05:17PM  UAW Trust Sought Drug-Price Risk Disclosures at The Wall Street Journal
04:02PM  Celgene's $7.2 Billion Makes a Big Splash at Motley Fool
02:22PM  Acquisitive Celgene aims to deal itself a blockbuster drug at Financial Times
12:41PM  Cramer Says Buy Celgene, Avoid AK Steel, Take FitBit Profits at TheStreet
11:48AM  Celgene (CELG) Stock Continues to Climb Following Receptos Acquisition at TheStreet
10:10AM  Company News for July 16, 2015 - Corporate Summary
05:59AM  Disney and Halliburton lock in post-industrial death match
Jul-15-15 11:49PM  Celgenes Receptos Deal Reveals Gap in Investors Thinking at The Wall Street Journal +6.95%
08:27PM  Jim Cramer's 'Mad Money' Recap: Take Notice of the Best Investors in the World at TheStreet
06:41PM  Netflix, Intel shares rally after earnings reports at MarketWatch
06:36PM  Biotech Leader Celgene Breaks Out From Base at Investor's Business Daily
05:51PM  Stock Market Today - 07/15/15
05:50PM  Fitbit Leads Trio Of Hot Health-Related IPO Stocks at Investor's Business Daily
05:32PM  CELGENE CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID for the treatment of multiple myeloma; and VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML). The company's products also include THALOMID for the patients with multiple myeloma and for the treatment of cutaneous manifestations of erythema nodosum leprosum; OTEZLA for psoriatic arthritis, psoriasis, and ankylosing spondylitis; ISTODAX to treat cutaneous and peripheral T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN LA products. Its clinical stage products comprise oral anti-inflammatory agents targeting PDE4, an intracellular enzyme that modulates the production of multiple pro-inflammatory and anti-inflammatory mediators; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; cellular therapies, such as PDA-001 and PDA-002 for Crohn's and peripheral arterial diseases; CC-486 to treat MDS, AML, and solid tumors; Sotatercept and luspatercept for the treatment of anemia; and CC-223 and CC-115 for lymphomas, hepatocellular, and prostate cancers. The company has collaborative agreements with Novartis Pharma AG; Acceleron Pharma; Agios Pharmaceuticals, Inc.; Epizyme Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; MorphoSys AG; Acetylon Pharmaceuticals, Inc.; OncoMed Pharmaceuticals, Inc.; and NantBioScience, Inc. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARIO ERNESTDirectorJun 16Option Exercise0.002,0550113,892Jun 16 06:57 PM
Daniel Thomas Osee remarksJul 28Option Exercise29.7736,3661,082,76085,252Jul 29 04:29 PM
Daniel Thomas Osee remarksJul 28Sale133.9629,7203,981,29155,532Jul 29 04:29 PM
Daniel Thomas Osee remarksJul 13Option Exercise29.0730,156876,59485,688Jul 15 04:30 PM
Daniel Thomas Osee remarksJul 13Sale120.7830,1563,642,24255,532Jul 15 04:30 PM
MARIO ERNESTDirectorJul 01Option Exercise0.007330141,891Jul 06 04:36 PM
KAPLAN GILLADirectorJul 01Option Exercise0.00733088,485Jul 06 04:35 PM
LOUGHLIN JAMES JDirectorJul 01Option Exercise0.00733021,885Jul 06 04:35 PM
COX CARRIE SMITHDirectorJul 01Option Exercise0.00733016,213Jul 06 04:33 PM
Friedman Michael ADirectorJul 01Option Exercise0.0073300Jul 06 04:34 PM
CASEY MICHAEL DDirectorJul 01Option Exercise0.0073300Jul 06 04:33 PM
BARKER RICHARD WDirectorJul 01Option Exercise0.0073309,590Jul 06 04:31 PM
KAPLAN GILLADirectorJun 16Option Exercise0.004,110087,752Jun 16 04:28 PM
COX CARRIE SMITHDirectorJun 16Option Exercise0.002,050015,480Jun 16 04:27 PM
CASEY MICHAEL DDirectorJun 13Option Exercise0.002,06800Jun 16 04:26 PM
BARKER RICHARD WDirectorJun 13Option Exercise0.002,06809,477Jun 16 04:26 PM
KAPLAN GILLADirectorJun 13Option Exercise0.002,068083,642Jun 16 04:28 PM
Friedman Michael ADirectorJun 13Option Exercise0.002,06800Jun 16 04:27 PM
MARIO ERNESTDirectorJun 13Option Exercise0.002,0680141,158Jun 16 04:29 PM
LOUGHLIN JAMES JDirectorJun 13Option Exercise0.002,068021,152Jun 16 04:28 PM
LOUGHLIN JAMES JDirectorJun 12Option Exercise0.002,066019,084Jun 16 04:28 PM
MARIO ERNESTDirectorJun 12Option Exercise0.002,0660139,090Jun 16 04:29 PM
Friedman Michael ADirectorJun 12Option Exercise0.002,06600Jun 16 04:27 PM
KAPLAN GILLADirectorJun 12Option Exercise0.002,066081,574Jun 16 04:28 PM
BARKER RICHARD WDirectorJun 12Option Exercise0.002,06608,028Jun 16 04:26 PM
CASEY MICHAEL DDirectorJun 12Option Exercise0.002,06600Jun 16 04:26 PM
KAPLAN GILLADirectorJun 10Option Exercise9.9315,000148,95094,508Jun 12 04:11 PM
KAPLAN GILLADirectorJun 10Sale111.7415,0001,676,10079,508Jun 12 04:11 PM
CASEY MICHAEL DDirectorJun 09Option Exercise9.931,80017,8741,800Jun 10 04:44 PM
CASEY MICHAEL DDirectorJun 09Sale110.501,800198,9000Jun 10 04:44 PM
CASEY MICHAEL DDirectorJun 08Option Exercise9.9313,200131,07613,200Jun 10 04:44 PM
CASEY MICHAEL DDirectorJun 08Sale111.2713,2001,468,7640Jun 10 04:44 PM
STEIN LAWRENCE VSee RemarksMay 14Option Exercise39.332,54299,97716,591May 15 04:30 PM
STEIN LAWRENCE VSee RemarksMay 14Sale114.852,542291,94914,049May 15 04:30 PM
KARSEN PERRY Asee remarksMay 13Option Exercise48.9430,4701,491,296109,993May 15 04:29 PM
Smith Scott AndrewSee RemarksApr 30Option Exercise0.006,666022,510May 04 07:16 PM
HUGIN ROBERT Jsee remarksApr 30Option Exercise0.0064,00001,217,315May 04 07:15 PM
KARSEN PERRY Asee remarksApr 30Option Exercise0.0011,200085,330May 04 07:15 PM
Daniel Thomas Osee remarksApr 30Option Exercise0.0011,200061,376May 04 07:14 PM
FOUSE JACQUALYN Asee remarksApr 30Option Exercise0.0011,200059,403May 04 07:14 PM
Alles Mark JSee RemarksApr 30Option Exercise0.0011,2000116,601May 04 07:13 PM
KARSEN PERRY Asee remarksMar 01Option Exercise0.008,334078,451Mar 03 04:24 PM
Daniel Thomas Osee remarksMar 01Option Exercise0.008,334054,524Mar 03 04:23 PM
FOUSE JACQUALYN Asee remarksMar 01Option Exercise0.008,334052,140Mar 03 04:24 PM
Alles Mark JSee RemarksMar 01Option Exercise0.008,3340109,479Mar 03 04:22 PM
KAPLAN GILLADirectorFeb 26Option Exercise8.4715,000127,02094,508Feb 27 04:14 PM
KAPLAN GILLADirectorFeb 26Sale122.8915,0001,843,35079,508Feb 27 04:14 PM
CASEY MICHAEL DDirectorFeb 25Option Exercise8.4715,000127,02015,000Feb 27 04:13 PM
CASEY MICHAEL DDirectorFeb 25Sale123.1915,0001,847,7900Feb 27 04:13 PM
Alles Mark JSee RemarksFeb 12Option Exercise45.4327,5051,249,653101,145Feb 17 04:44 PM
KARSEN PERRY Asee remarksFeb 11Option Exercise37.5227,8961,046,52098,013Feb 13 05:07 PM
KARSEN PERRY Asee remarksFeb 11Sale120.1227,8963,350,72870,117Feb 13 05:07 PM
Alles Mark JSee RemarksFeb 06Option Exercise41.75107,8594,503,114174,001Feb 10 06:46 PM
Alles Mark JSee RemarksFeb 06Sale120.68117,09914,131,15656,902Feb 10 06:46 PM
MARIO ERNESTDirectorFeb 03Option Exercise27.697,666212,272137,024Feb 04 04:11 PM
STEIN LAWRENCE VSee RemarksJan 15Option Exercise39.3324,124948,79730,858Jan 20 04:11 PM
STEIN LAWRENCE VSee RemarksJan 15Sale120.0126,6663,200,2534,192Jan 20 04:11 PM
KAPLAN GILLADirectorJan 02Option Exercise16.2145,536738,25245,536Jan 06 04:17 PM
KAPLAN GILLADirectorJan 02Sale113.4745,5365,167,1340Jan 06 04:17 PM
KARSEN PERRY Asee remarksDec 30Option Exercise29.7523,334694,18774,744Jan 02 04:01 PM
KARSEN PERRY Asee remarksDec 30Sale113.3719,2732,184,98055,471Jan 02 04:01 PM
Daniel Thomas Osee remarksDec 15Option Exercise29.7530,000892,50075,400Dec 17 04:03 PM
Daniel Thomas Osee remarksDec 15Sale115.0630,0003,451,87245,400Dec 17 04:03 PM
KAPLAN GILLADirectorDec 08Option Exercise7.0915,000106,38894,508Dec 10 04:41 PM
KAPLAN GILLADirectorDec 08Sale118.2015,0001,773,00079,508Dec 10 04:41 PM
Smith Scott AndrewSee RemarksNov 30Option Exercise0.006,67006,670Dec 02 04:14 PM
Daniel Thomas Osee remarksNov 24Option Exercise0.0033,818079,218Nov 26 04:32 PM
Daniel Thomas Osee remarksNov 24Sale110.2733,8183,729,11145,400Nov 26 04:32 PM
KARSEN PERRY Asee remarksNov 12Option Exercise32.9032,0741,055,39190,830Nov 14 04:13 PM
KARSEN PERRY Asee remarksNov 12Sale107.2339,4204,227,00751,410Nov 14 04:13 PM
HUGIN ROBERT Jsee remarksNov 03Option Exercise14.35744,40010,683,7501,769,158Nov 04 04:07 PM
HUGIN ROBERT Jsee remarksNov 03Sale106.68158,00016,855,4401,177,300Nov 04 04:07 PM
MARIO ERNESTDirectorOct 27Sale102.85100,00010,284,630129,358Oct 29 04:09 PM
CASEY MICHAEL DDirectorOct 24Option Exercise7.0915,000106,38815,000Oct 28 04:08 PM
CASEY MICHAEL DDirectorOct 24Sale102.9415,0001,544,1080Oct 28 04:08 PM
KAPLAN GILLADirectorSep 08Option Exercise7.2530,000217,425109,508Sep 10 05:14 PM
KAPLAN GILLADirectorSep 08Sale93.7330,0002,811,90079,508Sep 10 05:14 PM
KARSEN PERRY Asee remarksAug 04Option Exercise28.1646,4501,308,03297,860Aug 05 04:14 PM
KARSEN PERRY Asee remarksAug 04Sale87.5539,1043,423,43458,756Aug 05 04:14 PM
CVS CVS Health Corporation daily Stock Chart
CVS [NYSE]
CVS Health Corporation
IndexS&P 500 P/E27.55 EPS (ttm)4.10 Insider Own0.10% Shs Outstand1.13B Perf Week2.50%
Market Cap127.43B Forward P/E19.19 EPS next Y5.88 Insider Trans-15.46% Shs Float1.13B Perf Month8.03%
Income4.74B PEG1.85 EPS next Q1.20 Inst Own84.80% Short Float1.08% Perf Quarter14.11%
Sales143.01B P/S0.89 EPS this Y5.90% Inst Trans0.01% Short Ratio2.94 Perf Half Y13.56%
Book/sh32.79 P/B3.44 EPS next Y13.96% ROA6.40% Target Price116.67 Perf Year47.26%
Cash/sh1.45 P/C77.99 EPS next 5Y14.85% ROE12.50% 52W Range73.69 - 113.65 Perf YTD18.47%
Dividend1.40 P/FCF28.83 EPS past 5Y9.30% ROI10.30% 52W High-0.62% Beta0.98
Dividend %1.24% Quick Ratio0.70 Sales past 5Y7.20% Gross Margin17.90% 52W Low53.27% ATR1.49
Employees137800 Current Ratio1.30 Sales Q/Q11.10% Oper. Margin6.20% RSI (14)69.19 Volatility1.34% 1.25%
OptionableYes Debt/Eq0.35 EPS Q/Q12.60% Profit Margin3.30% Rel Volume0.94 Prev Close113.45
ShortableYes LT Debt/Eq0.32 EarningsAug 04 BMO Payout28.50% Avg Volume4.16M Price112.94
Recom1.70 SMA203.97% SMA507.40% SMA20014.96% Volume3,909,331 Change-0.45%
Jul-22-15Reiterated Deutsche Bank Hold $108 → $117
Jun-18-15Initiated Oppenheimer Outperform $119
Jun-09-15Initiated Macquarie Outperform $115
May-22-15Reiterated Jefferies Buy $120 → $125
Feb-13-15Reiterated Deutsche Bank Hold $100 → $109
Feb-11-15Reiterated RBC Capital Mkts Outperform $108 → $115
Feb-11-15Reiterated Mizuho Buy $103 → $113
Feb-11-15Reiterated Argus Buy $104 → $114
Dec-18-14Reiterated Argus Buy $95 → $105
Dec-17-14Reiterated RBC Capital Mkts Outperform $96 → $103
Nov-12-14Reiterated Mizuho Buy $85 → $103
Nov-05-14Reiterated RBC Capital Mkts Outperform $86 → $96
Nov-05-14Reiterated Argus Buy $85 → $95
Aug-06-14Reiterated RBC Capital Mkts Outperform $76 → $86
Aug-06-14Reiterated Mizuho Buy $81 → $85
Aug-06-14Reiterated Argus Buy $83 → $85
Aug-05-14Reiterated ISI Group Strong Buy $86 → $88
May-19-14Initiated Standpoint Research Strong Sell $62
May-05-14Reiterated Barclays Overweight $74 → $85
Apr-04-14Reiterated Argus Buy $77 → $83
Jul-30-15 10:01PM  Lawsuit accuses CVS of overcharging for generic drugs
07:41PM  Lawsuit accuses CVS Health of overcharging for generic drugs
06:37PM  Moody's Upgrades One, Affirms Three and Downgrades One Class of GMAC 1999-C2 at Moody's
04:43PM  Rite Aid Rises On 'Positive' July Sales; CVS And Walgreens? at Investor's Business Daily
04:35PM  How IBM's Watson Can Help CVS Customers
03:33PM  Cardinal Health (CAH) Earnings Report: Q4 2015 Conference Call Transcript at TheStreet
02:55PM  CVS partners with IBM to mine all your health data at bizjournals.com
12:24PM  CVS pharmacy is bringing IBM's doctor-like supercomputer Watson into its 7,800 stores
09:00AM  CVS Health Announces New Clinical Affiliations with Lawrence Memorial Hospital and Lehigh Valley Health Network PR Newswire
06:00AM  CVS Health and IBM Tap Watson to Develop Care Management Solutions for Chronic Disease PR Newswire
12:06AM  CVS, IBM partner for technology-based health care at USA TODAY
12:01AM  CVS Health, IBM plot Watson deployment
12:01AM  IBM, CVS Will Use Watson Health Technology to Improve Patient Care at TheStreet
12:00AM  CVS And IBM's Watson Cloud Pursue Ways To Predict Patient Health at Forbes
Jul-29-15 05:18PM  CVS and Walgreens are completely dominating the US drugstore industry
Jul-28-15 05:03PM  Express Scripts Raises Guidance as Earnings Top Views at The Wall Street Journal
11:10AM  Can Cardinal Health's (CAH) Q4 Earnings Pull a Surprise? - Analyst Blog
Jul-27-15 10:48AM  How does the role of Medicare/Medicaid affect the drugs sector in the U.S.? at Investopedia
10:05AM  Investment-Grade Bond Funds Experience Back-to-Back Inflows
09:36AM  JP Morgan Downgrades Omnicare Following CVS Deal
09:05AM  Full Interview: Allergan's CEO On Selling His Generics Business And What He'll Buy Next at Forbes
Jul-25-15 02:53AM  Research Reports at Barrons.com
Jul-24-15 03:59PM  Battle coming for blockbuster cholesterol drugs at CNBC
07:03AM  Omnicare Reports Second-Quarter 2015 Financial Results ACN Newswire
Jul-23-15 12:00PM  CVS Health Corporation To Hold Second Quarter 2015 Conference Call PR Newswire
06:30AM  Robots need not apply at Fortune
Jul-22-15 02:17PM  Learning from Starbucks on job creation at CNBC
12:04PM  Companies escalate jumbo debt sales at Financial Times
11:07AM  CVS Health Issues Most High-Grade Bonds in Week Ended July 17
10:05AM  Stock Price and Valuation Trends for Food and Drug Retailers
10:05AM  Key Trends Shaping Food and Drug Retailers
09:12AM  CVS Health (CVS) Stock Price Target Raised at Deutsche Bank at TheStreet
Jul-21-15 08:45PM  Customer Data Breach Hits CVS Health Photo Site at Investopedia
07:05AM  CVS Goes Shopping: Financing the Target Purchase
06:50AM  CVS, Costco investigating data breach at online photo services at bizjournals.com
Jul-20-15 07:05PM  How Proposed Acquisitions Impact CVS Growth and Capitalization
07:05PM  Why the Target Deal Is a Winner for CVS Health
06:04PM  Costco, Sam's Club, others halt photo sites over possible breach
01:41PM  Photo sites remain offline in wake of possible hack
01:39PM  CVS HEALTH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10:21AM  PayPal Enters a Brave New World of Money Disruption at The Wall Street Journal
07:21AM  7 things to know about today, plus why baby boomers may be in financial trouble at bizjournals.com
Jul-17-15 04:50PM  CVS HEALTH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
02:32PM  CVS Photo website credit card info possibly stolen in breach
Jul-16-15 04:16PM  Ulta Beauty Is In The Eye Of The Shareholders at Investor's Business Daily
Jul-15-15 11:06AM  How the CVSTarget Deal Trims the Fat
09:06AM  How CVS Plans to Make Targets Pharmacies Profitable
08:02AM  3 Pharmacy Benefit Manager Stocks to Watch at Motley Fool
Jul-14-15 07:00PM  Cramer: Wake up or you'll miss these stocks
11:49AM  CVS Health chief: Consumers care more about wallet than health at Fortune
11:36AM  Why Did eBays PayPal Acquire Money Transfer Company Xoom?
11:07AM  Mapping the Strategic Shifts in Targets Businesses
09:07AM  Mapping the Store Traffic Attractors in the TargetCVS Deal
08:00AM  CVS takes high road in clash with business group at Los Angeles Times
07:47AM  Can value shares catch up to 'glamour' growth stocks like Netflix?
Jul-13-15 08:41PM  Beauty Care Becoming Key to Retail Growth at Investopedia
02:41PM  TREASURIES-Yields rise on Greek deal, corporate bond sale weighs Reuters
09:25AM  Major US Companies to Add 100,000 Jobs
08:15AM  Greek deal celebration; Starbucks' jobs initiative; Chipotle's pork solution
08:02AM  UnitedHealth Set For Q2 Earnings Amid Deal Chatter at Investor's Business Daily
Jul-10-15 09:45PM  CVS Health Stubs Out U.S. Chamber Membership at Investopedia
01:25PM  A tale of two drugstores: Walgreens upgraded while rival Rite Aid downgraded at MarketWatch
Jul-09-15 06:42PM  Walgreens Profit Tops, Big Sales Hike Doesn't, But Pessina, Alliance Boots Just Warming Up
04:04PM  This Week's Top Healthcare News Could Cause These Stocks Pop or Drop at Motley Fool
02:57PM  Novartis Meets Skepticism in Plan to Link Drug Pay to Outcomes at Bloomberg
02:03PM  Walgreens Boots makes Pessina permanent CEO
08:50AM  Walgreens Taps Italian Billionaire Pessina As Permanent CEO at Forbes
Jul-08-15 06:26PM  Moody's Upgrades One and Affirms Two Classes of LBUBS 2000-C4 at Moody's
12:10PM  CVS Health Corporation Announces Quarterly Dividend PR Newswire
10:30AM  CVS Health leaving U.S. Chamber of Commerce over smoking spat at Fortune
07:42AM  Early movers: HOG, TSLA, WWE, MSFT, BCS & more at CNBC
06:00AM  CVS quits Chamber of Commerce
Jul-07-15 09:14PM  CVS Leaves Chamber of Commerce Over Smoking Stance at The Wall Street Journal
06:27PM  CVS leaving U.S. Chamber of Commerce in tobacco tiff at Los Angeles Times
05:47PM  CVS leaving US Chamber of Commerce in tobacco tiff
04:08PM  CVS Health quits U.S. Chamber of Commerce over tobacco stance Reuters
03:51PM  CVS quits powerful U.S. Chamber of Commerce in dispute over tobacco lobbying at MarketWatch
11:51AM  Target and CVS Make for a Healthy Business Combination at TheStreet
Jul-06-15 01:29PM  Walgreens To Report Q3 Amid Industry Consolidation at Investor's Business Daily
09:44AM  Aetna CEO says built expectations for asset sales into deal
Jul-02-15 01:41PM  Business events scheduled for Friday
Jul-01-15 04:20PM  Consumer Staple ETFs Remain Steady In 2015
01:52PM  New ETFs Offers a new Spin on Low Volatility
Jun-30-15 02:40PM  Rite Aid (RAD) Appoints Everett to Lead Store Operations - Analyst Blog
10:26AM  Do Data Breaches Really Matter for Retailers? at Investopedia
09:46AM  3 Ways Rite Aid Is Transforming Before Our Very Eyes at Motley Fool
Jun-29-15 09:06AM  The Worst Companies To Work For
Jun-26-15 05:33PM  Same-Sex Marriage Decision Eases Data Burden for Companies at The Wall Street Journal
06:27AM  Business events scheduled for the coming month
Jun-25-15 04:13PM  Key Target merchandising exec steps aside
11:02AM  Obamacare subsidies upheld, Uber protests and cash for beer drinkers
10:35AM  Pittsburgh Business Group on Health-CVS contract could save members $75M on drug costs at bizjournals.com
Jun-24-15 05:00PM  2 Stocks to Watch in Retail at Motley Fool
08:30AM  CVS Health Announces New Clinical Affiliations with Four Leading Health Care Organizations PR Newswire
03:18AM  Edited Transcript of CVS presentation 23-Jun-15 2:30pm GMT
Jun-23-15 01:31PM  These stocks will move when the Supreme Court rules on Obamacare
01:25PM  Does CVS Really Need $20 Billion More in Debt for Acquisitions?
01:10PM  CVS President Helena Foulkes on how a tobacco-free CVS plans to make up $2B in lost revenue at bizjournals.com
10:48AM  Obamacare ruling, Taylor Swift's Apple saga, and Amazon still selling Confederate flag
10:30AM  CVS Health Announces New Chief Marketing Officer PR Newswire
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The Pharmacy Services segment offers pharmacy benefit management services, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private organizations, other sponsors of health benefit plans, and individuals under the CVS/caremark Pharmacy Services, Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, Coram CVS/specialty, NovoLogix, and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. As of December 31, 2014, it operated 7,822 retail drugstores, 860 health care clinics, 17 onsite pharmacy stores, 27 retail specialty pharmacy stores, 11 specialty mail order pharmacies, 4 mail service dispensing pharmacies, and 86 branches, as well as 6 centers of excellence for infusion and enteral services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boratto Eva CSVP, Cont & Chief Acct OfficerJul 20Option Exercise30.1622,107666,74746,408Jul 21 04:19 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerJul 20Sale110.3422,1072,439,27524,301Jul 21 04:19 PM
Bisaccia LisaEVP, Chief HR OfficerJul 15Option Exercise51.1141,9822,145,68233,061Jul 16 04:31 PM
Bisaccia LisaEVP, Chief HR OfficerJul 15Sale110.0049,9085,489,94921,003Jul 16 04:31 PM
BROWN C DAVID IIDirectorJun 01Sale102.5710,0001,025,70091,252Jun 02 04:13 PM
BROWN C DAVID IIDirectorMay 01Sale100.2715,0001,504,050101,252May 04 04:41 PM
Sussman AndrewEVP & Pres, CVS/minuteclinicApr 10Option Exercise49.5212,556621,72220,598Apr 13 04:20 PM
Sussman AndrewEVP & Pres, CVS/minuteclinicApr 10Sale102.3817,6381,805,8298,861Apr 13 04:20 PM
Brennan Troyen AEVP, Chief Medical OfficerApr 02Option Exercise45.0716,637749,83078,478Apr 03 04:56 PM
Brennan Troyen AEVP, Chief Medical OfficerApr 02Sale102.7116,6371,708,78661,841Apr 03 04:56 PM
Brennan Troyen AEVP, Chief Medical OfficerApr 01Option Exercise34.9616,747585,47574,257Apr 03 04:56 PM
Brennan Troyen AEVP, Chief Medical OfficerApr 01Sale102.2616,7471,712,54857,510Apr 03 04:56 PM
Brennan Troyen AEVP, Chief Medical OfficerMar 23Option Exercise45.0733,2741,499,65988,360Mar 24 04:12 PM
Brennan Troyen AEVP, Chief Medical OfficerMar 23Sale104.9433,2743,491,77455,086Mar 24 04:12 PM
BROWN C DAVID IIDirectorMar 20Sale104.3025,0002,607,500116,252Mar 23 04:19 PM
Roberts Jonathan CEVP & President, CVS/caremarkJan 07Option Exercise41.1786,4873,560,670117,955Jan 08 04:12 PM
Roberts Jonathan CEVP & President, CVS/caremarkJan 07Sale95.3186,4878,243,07631,468Jan 08 04:12 PM
MERLO LARRY JPresident and CEOJan 05Option Exercise41.17144,1445,934,408220,273Jan 06 05:33 PM
MERLO LARRY JPresident and CEOJan 05Sale94.30144,14413,592,77976,129Jan 06 05:33 PM
Lofberg Per GHEVPJan 02Option Exercise45.07347,34315,654,749370,762Jan 05 04:52 PM
Brennan Troyen AEVP, Chief Medical OfficerJan 02Option Exercise34.9650,2401,756,39091,487Jan 05 04:58 PM
Lofberg Per GHEVPJan 02Sale95.28347,34333,096,43923,419Jan 05 04:52 PM
Sussman AndrewSVP & Pres, CVS/minuteclinicJan 02Sale95.674,220403,7132,817Jan 05 05:00 PM
Brennan Troyen AEVP, Chief Medical OfficerJan 02Sale95.7150,2404,808,51641,247Jan 05 04:58 PM
Foulkes HelenaEVP, President-CVS/pharmacyNov 07Option Exercise39.3246,3251,821,35838,040Nov 10 05:11 PM
Foulkes HelenaEVP, President-CVS/pharmacyNov 07Sale88.0646,3254,079,58418,076Nov 10 05:11 PM
Bisaccia LisaSVP, Chief HR OfficerOct 27Option Exercise40.6527,5861,121,39538,730Oct 28 04:07 PM
Bisaccia LisaSVP, Chief HR OfficerOct 27Sale85.0033,5072,848,09517,281Oct 28 04:07 PM
Sussman AndrewSVP & President, MinuteClinicSep 02Option Exercise36.969,020333,37916,057Sep 03 04:43 PM
Sussman AndrewSVP & President, MinuteClinicSep 02Sale79.459,020716,6397,037Sep 03 04:43 PM
Joyner J. DavidEVP, Sales & Account ServicesAug 06Option Exercise31.12123,5163,843,942123,018Aug 07 04:14 PM
Joyner J. DavidEVP, Sales & Account ServicesAug 06Sale76.10123,5169,399,56845,399Aug 07 04:14 PM
XLV Health Care Select Sector SPDR ETF daily Stock Chart
XLV [NYSE]
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.79%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month2.32%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter6.56%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y8.89%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year24.11%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range58.63 - 77.40 Perf YTD12.06%
Dividend0.97 P/FCF- EPS past 5Y- ROI- 52W High-1.61% Beta-
Dividend %1.27% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low29.89% ATR0.88
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)52.86 Volatility1.24% 1.01%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.68 Prev Close76.26
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume7.87M Price76.15
Recom- SMA200.41% SMA501.20% SMA2006.98% Volume5,371,500 Change-0.14%
Jul-30-15 03:42PM  The Cigna-Anthem Merger: Background on Cigna
11:07AM  CignaAnthem Merger: Why Scale Matters to Health Insurers
09:29AM  Reaping the Benefits of an Aging World Market Realist
09:06AM  How the CignaAnthem Merger Will Go Down
09:06AM  Novartiss Shares Fall after 2Q15 Earnings
08:05AM  Earnings halftime scorecard
Jul-29-15 11:06AM  Why Sandoz Revenues Were Important for Novartis in 2Q15
09:58AM  The Huge Spread on the CignaAnthem Merger
09:58AM  Cigna Accepts Anthems Higher Offer
09:06AM  Why Alcons Performance Was Weak in 2Q15
Jul-28-15 11:46AM  Why Novartiss Revenues Declined Marginally
11:45AM  Novartiss Adjusted Earnings per Share Declined 7% in 2Q15
09:06AM  Leading Economic Index Indicates Steady Growth in the US
07:44AM  Dissecting big pharma's numbers: Pro
07:09AM  Buy market dips and focus on growth: Pro
Jul-27-15 09:23AM  Investing With A High Probability Of Global Recession at Forbes
Jul-24-15 03:19PM  Doctors fight to lower cancer drugs cost
07:46AM  3D printing: Revolutizing prosthetics and sports
Jul-22-15 03:06PM  Is UnitedHealth Group a Better Partner for Cigna?
03:06PM  The CignaAnthem Deal: Whats in It for Cigna?
08:44AM  ETF Analysis: Health Care Select Sector SPDR at Investopedia
Jul-21-15 01:26PM  Anthem Should Benefit by Acquiring Cigna
01:24PM  Will Anthem Acquire Cigna?
08:05AM  Parsing the Humana-Aetna MAE Clause
Jul-18-15 09:13AM  The Week Ahead: Damn the Torpedoes .... at Forbes
Jul-17-15 02:20PM  UCLA health system hacked
09:25AM  How Can Changing Demographics Impact Investors?
08:00AM  Shark Tank's Mr. Wonderful has 'sit and wait' stock-picking strategy
Jul-16-15 02:05PM  A Deeper Look into the Humana-Aetna MAE Clause
01:06PM  What Does the Humana-Aetna Material Adverse Effect Clause Say?
07:05AM  How to Trade the Deal between Humana and Aetna
Jul-15-15 04:06PM  What Is the Risk-to-Reward Ratio of the HumanaAetna Deal?
04:06PM  Could Competing Bids Disrupt Aetnas Purchase of Humana?
03:54PM  Health care pick: Becton Dickinson
01:05PM  Some Good Reasons Why Aetna Wants to Consolidate with Humana
12:05PM  The Aetna-Humana Deal: Must-Know Risks to Consider
Jul-14-15 11:56AM  Two Sectors Breaking Out at Forbes
Jul-13-15 04:16PM  What to expect from Johnson & Johnsons earnings at MarketWatch
11:29AM  Why The Next 10% Move In U.S. Stocks Is Higher, Not Lower at Forbes
Jul-12-15 09:05AM  Antitrust Is the Biggest Risk in the HumanaAetna Deal
09:05AM  The Aetna-Humana Deal: Analyzing Market Response
Jul-10-15 06:59PM  Health Care, Financial Stocks Will Have a Better 2Q Earnings Season at TheStreet
04:42PM  New wave of digital health
11:06AM  Aetna Projects Annual Synergies through Its Humana Acquisition
08:45AM  A Live Lesson in Value-Investing: The Energy Meltdown
Jul-09-15 03:20PM  What to Buy in Biotech at Barrons.com
02:56PM  Whats on the Line with Aetnas Proposed Acquisition of Humana?
02:56PM  Humana and Aetna Test the Post-Obamacare Landscape
09:06AM  Why Did Aetna Target Humana for an Acquisition?
Jul-08-15 05:38PM  Safe Places to Stash Your Cash During the Stormy Market Ahead at TheStreet
10:09AM  Aetna Announces Its Acquisition of Humana
Jul-07-15 03:16PM  Equity ETFs Added Asses in June Despite Market Declines
10:43AM  Time for a quick Surf Break
08:55AM  These are the market's bright spots right now: Strategist
Jul-06-15 01:16PM  Monday ETF Winners: Health Care ETF Inches Up On Deals at Investor's Business Daily
08:51AM  Health care's urge to merge
Jul-01-15 04:47PM  Health Care Bull Market Will Continue, Charts Say at Barrons.com
01:37PM  Best play for rest of 2015
12:19PM  Sector ETFs' Technical Charts Suggest Drag on S&P 500 at TheStreet
07:00AM  Valuations Across the Sectors of the S&P 500 at Morningstar
Jun-30-15 02:59PM  Greece Crisis Has Yet to Create Buying Opportunity in U.S. Stocks at TheStreet
10:45AM  4 Health Care Investments to Boost Your Portfolio
10:18AM  Stocks in the first half offer a very mixed bag at CNBC
Jun-29-15 01:57PM  Consumer spending again: Pro
12:33PM  Labor Market Strength Is Reflected in Steadying Jobless Claims
Jun-26-15 10:39AM  The case for staying domestic
07:08AM  Long-term impact of ACA? More costs: Pro
06:33AM  Next step for Obamacare?
Jun-25-15 04:30PM  Scalia's having a tantrum: Barney Frank
04:01PM  Transports' weakness in focus
03:52PM  Market dealing with near-term uncertainty: Pro
03:04PM  Supreme Court decision lifts health care
03:04PM  M&A heating up in health
02:00PM  Report: Aetna close to buying Humana
12:59PM  Halftime's hottest trades: NKE, DIS, DE, & high-yield
12:06PM  Is the Cigna-Anthem Merger a Setup?
11:46AM  Time wasted voting to appeal: Pro
11:40AM  Cashin says: Health care ruling sparks rally
11:38AM  Obama: Law working better than we expected
11:35AM  Obama: This is a victory for Americans
11:34AM  Obama: Affordable Care Act is here to stay
11:33AM  Boehner: Continue efforts to put Americans back in charge
11:30AM  Boehner: Veterans Affairs problem is failure
11:30AM  Boehner: Obamacare is fundamentally broken
11:02AM  Obamacare subsidies upheld, Uber protests and cash for beer drinkers
11:01AM  Healthcare may not be on the front burner: Pro
10:33AM  Controversy not over, big win for administration: Pro
10:23AM  Energy players could be a long term play: Pro
10:12AM  High court backs White House on health law
Jun-24-15 04:25PM  The Spark: Hospitals take on Yelp
01:46PM  Traders see money in this drug stock at CNBC
01:23PM  Traders "like" Facebook in trades to go at CNBC
12:57PM  Top trades for the 2nd half: AAPL, FB & XLV
10:06AM  Biotech sensitive to interest rates: Pro
08:20AM  Time for Some Tech With a Favored ETF
07:40AM  'I can't buy that stock, its overbought!' - Beyonce
Jun-23-15 02:03PM  Anthem Files Bear Hug Letter for Cigna on June 21
10:44AM  Moving closer to the Edge
06:40AM  Are Americans becoming health care dropouts?
Jun-22-15 02:49PM  Skeptical Sentiment In A Sideways Market: Bullish Or Bearish For Stocks?
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
CAG ConAgra Foods, Inc. daily Stock Chart
CAG [NYSE]
ConAgra Foods, Inc.
IndexS&P 500 P/E- EPS (ttm)-1.46 Insider Own0.30% Shs Outstand428.86M Perf Week1.58%
Market Cap19.06B Forward P/E18.40 EPS next Y2.42 Insider Trans-33.02% Shs Float427.39M Perf Month2.23%
Income-620.90M PEG- EPS next Q0.40 Inst Own78.80% Short Float1.76% Perf Quarter23.64%
Sales15.83B P/S1.20 EPS this Y-494.60% Inst Trans4.18% Short Ratio2.09 Perf Half Y23.38%
Book/sh10.58 P/B4.20 EPS next Y8.10% ROA-1.40% Target Price45.70 Perf Year49.59%
Cash/sh0.43 P/C104.09 EPS next 5Y6.53% ROE-5.00% 52W Range29.11 - 45.23 Perf YTD24.88%
Dividend1.00 P/FCF32.66 EPS past 5Y-24.90% ROI-2.20% 52W High-1.74% Beta0.38
Dividend %2.25% Quick Ratio0.40 Sales past 5Y5.70% Gross Margin21.80% 52W Low52.64% ATR0.61
Employees32900 Current Ratio1.10 Sales Q/Q3.70% Oper. Margin0.30% RSI (14)64.47 Volatility1.26% 1.36%
OptionableYes Debt/Eq1.75 EPS Q/Q150.50% Profit Margin-1.60% Rel Volume0.59 Prev Close44.13
ShortableYes LT Debt/Eq1.52 EarningsJun 30 BMO Payout- Avg Volume3.59M Price44.44
Recom2.70 SMA200.62% SMA507.34% SMA20020.64% Volume2,106,281 Change0.70%
Jul-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $37 → $50
Jul-01-15Upgrade BofA/Merrill Underperform → Neutral
Jun-22-15Upgrade JP Morgan Neutral → Overweight
Jun-19-15Reiterated Deutsche Bank Hold $36 → $38
Jun-19-15Reiterated Bernstein Mkt Perform $37 → $44
Sep-19-14Reiterated RBC Capital Mkts Sector Perform $31 → $35
Feb-12-14Reiterated Deutsche Bank Hold $35 → $31
Nov-26-13Initiated RBC Capital Mkts Sector Perform $33
Sep-11-13Reiterated Barclays Overweight $40 → $38
Apr-03-13Reiterated Deutsche Bank Hold $35 → $40
Feb-20-13Reiterated Deutsche Bank Hold $31 → $32
Jan-24-13Reiterated UBS Buy $38 → $36
Nov-28-12Reiterated Deutsche Bank Hold $29 → $31
Sep-21-12Upgrade UBS Neutral → Buy $27 → $31
Jul-25-12Initiated KeyBanc Capital Mkts Buy $30
May-05-11Reiterated Deutsche Bank Hold $23 → $28
Sep-22-10Reiterated Barclays Capital Equal Weight $27 → $25
Sep-17-10Reiterated Deutsche Bank Hold $26 → $25
Mar-22-10Reiterated Credit Suisse Neutral $24 → $27
Sep-23-09Reiterated Credit Suisse Neutral $21 → $24
Jul-30-15 08:00AM  ConAgra Foods Removes BPA from Cans across Portfolio Business Wire
Jul-28-15 06:08PM  Exclusive: TreeHouse, Post join ConAgra's private label auction - sources Reuters
09:57AM  A Hostile Environment: The M&A Landscape in 2015 at Forbes
Jul-22-15 05:33PM  Apple Who? 3 Stocks Crushing iPhone Maker, Market at Investor's Business Daily
03:37PM  Accenture is the latest major company to ditch dreaded annual reviews
01:04PM  CONAGRA FOODS INC /DE/ Financials
Jul-17-15 04:05PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
11:44AM  CONAGRA FOODS INC /DE/ Files SEC form 10-K, Annual Report
Jul-14-15 01:01PM  During Kids Eat Right Month, Teach Kids The Importance Of Food Safety PR Newswire
08:23AM  ConAgra Foods Announces Dividend Payment Business Wire
Jul-13-15 01:18PM  Justice Dept.: Food companies risk prosecution for outbreaks
Jul-10-15 12:17PM  Activist Investor Barry Rosenstein Enters Into Agreement With ConAgra Foods Inc. (CAG); Board Expanded To 14 Members at Insider Monkey
Jul-09-15 12:50PM  4 Stocks, 4 trades: YHOO, WBA, CAG & NFLX
12:11AM  ConAgra Expands Board in Agreement With Jana Partners at The Wall Street Journal
Jul-08-15 06:30PM  ConAgra, General Mills Near Highs As Food Prices Rise at Investor's Business Daily
06:15PM  ConAgra Expands Board in Agreement With Jana Partners at The Wall Street Journal
05:47PM  ConAgra Adds Two Board Members in Standstill With Activist Jana at Bloomberg
05:36PM  ConAgra appoints Jana Partners' nominee to board
05:24PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statem
05:00PM  ConAgra Foods and JANA Partners Announce Appointments of Bradley A. Alford and Timothy R. McLevish to ConAgra Foods' Board of Directors Business Wire
04:19PM  ConAgra turns to Centerview again for advice on Ralcorp -sources Reuters
03:50PM  Second time around, Ralcorp likely to sell for less at bizjournals.com
Jul-07-15 12:03PM  ConAgra Foods Will Continue to Prosper
11:04AM  Its Baaaackk: Q2 Earnings season kicks off this week, could it be the worst quarter since 2009?
Jul-06-15 02:55PM  ConAgra Hits 52-Week High on New Business Strategies - Analyst Blog
Jul-03-15 09:55AM  Heres what CEOs said about the economy last week
07:23AM  Acuity Brands, ConAgra, Fitbit -- Two to Buy, One to Sell on Their Highs at TheStreet
01:07AM  Last Week at Barrons.com
Jul-02-15 09:27PM  Why ConAgra Is Finally Dumping Private-Label Goods at Investopedia
03:18PM  Dealpolitik: ConAgra Pays for Disastrous Takeover Strategy at The Wall Street Journal
02:31PM  Break Up ConAgra: What Is It Worth? at Barrons.com
12:55PM  Tonawanda cookie facility to be part of ConAgra divestiture at bizjournals.com
08:35AM  Top Analyst Upgrades and Downgrades: AT&T, Capstone, ConAgra, Diamond Offshore, Hecla Mining and More at 24/7 Wall St.
08:03AM  Analysts' Actions -- Avis, ConAgra, Energizer and More
06:27AM  ConAgra upgraded by Morgan Stanley
Jul-01-15 03:49PM  S&P Puts ConAgra On Review On Private Label Sale at Barrons.com
11:00AM  Bank Of America Upgrades ConAgra, Sees Door Open For 'Other' Strategic Options
10:10AM  5 Best Stocks in the S&P 500 for June at 24/7 Wall St.
08:37AM  Treehouse Foods (THS) in Focus: Stock Moves 9.3% Higher - Tale of the Tape
08:00AM  ConAgra Is Overbought and Needs a Healthy Pullback at TheStreet
12:37AM  ConAgra Plans to Exit Private Brands at The Wall Street Journal
Jun-30-15 06:21PM  AeroVironment shares rise on boost in drone sales at MarketWatch
04:25PM  Treehouse Foods and Sony are big market movers
04:06PM  Stocks End Higher on Hopes Greece Could Delay Rate Hike at TheStreet
04:05PM  ConAgra Plans to Exit Private Brands at The Wall Street Journal
03:38PM  ConAgra Foods, Inc. -- Moody's affirms ConAgra ratings; revises outlook to developing at Moody's
03:08PM  Conagra Foods (CAG) Earnings Report: Q4 2015 Conference Call Transcript at TheStreet
02:56PM  Four Dos and Donts to Avoid ConAgras Merger Mistake: Real M&A at Bloomberg
02:09PM  ConAgra: a private matter at Financial Times
01:41PM  Stocks higher amid Greece talks; biotechs boost Nasdaq at CNBC
01:36PM  ConAgra Meets Q4 Earnings Estimates, Exits Private Brands - Analyst Blog
01:33PM  TreeHouse, Post Seen As ConAgra Private Brand Buyers at Investor's Business Daily
01:21PM  Mid-Day Market Update: Juno Therapeutics Jumps Following Announcement of 10-Year Collaboration With Celgene
01:16PM  ConAgra is Selling, Is TreeHouse Buying? at Barrons.com
01:01PM  ConAgra Foods pulls plug on private brands unit at Financial Times
12:42PM  ConAgra to sell store-brand food business
12:33PM  ConAgra Foods to exit struggling private label business
12:30PM  Its official: ConAgra divesting Ralcorp; Post leads potential buyers at bizjournals.com
11:44AM  ConAgra shares rise on plan to sell off private brands at USA TODAY
11:17AM  ConAgra to dump private label business after pressure from activist investor Jana at Fortune
10:47AM  ConAgra Plan to Exit Private Label Food Business Boosts Shares at TheStreet
10:32AM  Mid-Morning Market Update: Markets Rise; ConAgra Foods Plans To Exit Private Label Business
10:00AM  CAG shares rally on private label exit
09:35AM  ConAgra Foods Inc (CAG) Meets Earnings Expectations, Time To Buy In? at Insider Monkey
09:30AM  ConAgra Foods Inc Earnings Call scheduled for 9:30 am ET today
09:28AM  ConAgra (CAG) Q4 Earnings In-line, Lags Revenues - Tale of the Tape
08:48AM  A wicked spike in volatility is putting the bull market at risk at MarketWatch
08:43AM  ConAgra Investors Cheer Private Brands Exit
08:38AM  ConAgra Foods (CAG) Stock Gains Following Fourth Quarter Earnings Release at TheStreet
08:29AM  ConAgra to sell sell store-brand food business
07:57AM  Early movers: PNR, CAG, GE, FIT, JUNO, GM & more at CNBC
07:53AM  ConAgra shares up as company says will exit private-label business at MarketWatch
07:46AM  ConAgra meets 4Q profit forecasts
07:41AM  ConAgra Foods to exit private label business
07:37AM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
07:30AM  ConAgra Foods Fourth-Quarter EPS Grows as Planned; Outlines New Strategic Direction; Plans to Exit Private Label Business Wire
07:07AM  Q4 2015 ConAgra Foods Inc Earnings Release - Before Market Open
06:50AM  Greeces D(efault)-Day and ConAgra updates investors5 things to know today at Fortune
05:58AM  US stocks seen up; Greece expected to miss payment at CNBC
Jun-29-15 08:15PM  What to Watch Tuesday -- Greek Crisis, ConAgra Earnings, Consumer Confidence at TheStreet
06:25PM  What To Look For When General Mills Reports Wednesday at Investor's Business Daily
06:06PM  Why Jim Cramer Is Awaiting ConAgra's Latest Earnings at TheStreet
05:32PM  What's in Store for ConAgra (CAG) this Earnings Season? - Analyst Blog
04:25PM  JANA Preys on ConAgra. What to Expect from Tomorrows Result.
04:19PM  What to Expect When ConAgra Foods (CAG) Posts Earnings Tuesday at TheStreet
04:08PM  Jim Cramer Is Watching ConAgra as the Company Posts Q4 Results Tuesday at TheStreet
03:35PM  ConAgra Foods Expected To Report Single-Digit EPS Growth
03:05PM  What to Watch in the Day Ahead - Tuesday, June 30 Reuters
01:37PM  15 Billion-Dollar Companies With Negative Net Earnings
11:35AM  What to Expect From ConAgra Earnings
12:24AM  ConAgras New CEO to Talk Strategy at The Wall Street Journal
Jun-28-15 09:12PM  Food & Beverage Giants Highlight This Week's Earnings
08:02PM  ConAgra's New CEO to Talk Strategy at The Wall Street Journal
05:01PM  Greeces drama, jobs, and holiday travel 5 things to watch for this week at Fortune
09:15AM  5 Key Earnings for the Week Ahead at 24/7 Wall St.
09:01AM  U.S. investors brace for more Greece debt drama at MarketWatch
Jun-27-15 12:12AM  13D Filings at Barrons.com
Jun-26-15 06:00PM  Cramer: Next week bookended by Greece & jobs
07:23AM  ConAgra Earnings Likely to Benefit From Activist Initiatives at TheStreet
Jun-25-15 03:14PM  How Bad Are Negative Q2 Earnings Revisions? - Earnings Preview
ConAgra Foods, Inc. operates as a food company primarily in North America. The company operates through three segments: Consumer Foods, Commercial Foods, and Private Brands. The Consumer Foods segment provides branded food products in various categories, such as meals, entrees, condiments, sides, snacks, and desserts to various retail channels, such as frozen, refrigerated, and shelf-stable temperature classes. This segment's principal brands include ACT II, Banquet, Blue Bonnet, Chef Boyardee, DAVID, Egg Beaters, Healthy Choice, Hebrew National, Hunt's, Marie Callender's, Orville Redenbacher's, PAM, Peter Pan, Reddi-wip, Slim Jim, Snack Pack, Swiss Miss, Van Camp's, and Wesson. The Commercial Foods segment offers frozen and sweet potato items, vegetable products, spices, bakery goods, and grain products to commercial, restaurants, foodservice, food manufacturing, and industrial customers under the Alexia, Lamb Weston, and Spicetec Flavors & Seasonings brands. The Private Brands segment offers private brand and customized food products in various retail channels, including bars, cereal, snacks, condiments, pasta, and retail bakery products. ConAgra Foods, Inc. was founded in 1919 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wise Robert GSVP, Corporate ControllerJul 16Option Exercise0.007,000020,883Jul 20 04:22 PM
Werner Thomas P.President, Commercial FoodsJul 16Option Exercise0.009,00009,000Jul 20 04:21 PM
JURGENSEN WILLIAM GDirectorJul 10Option Exercise22.819,000205,290105,820Jul 10 05:05 PM
STINSON KENNETH EDirectorJul 10Option Exercise22.819,000205,290101,524Jul 10 05:06 PM
GOLDSTONE STEVEN FDirectorJul 10Option Exercise22.819,000205,29098,167Jul 10 05:04 PM
BUTLER STEPHEN GDirectorJul 10Option Exercise22.819,000205,29073,882Jul 10 05:03 PM
Ross Andrew GeorgeEVP and CSOApr 09Option Exercise24.7484,0002,078,16098,839Apr 13 04:36 PM
Ross Andrew GeorgeEVP and CSOApr 09Sale37.7564,7702,445,31434,069Apr 13 04:36 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyApr 08Option Exercise24.7435,347874,485163,142Apr 09 04:29 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyApr 08Sale37.9335,3471,340,733127,795Apr 09 04:29 PM
BAY MOGENS CDirectorApr 07Option Exercise22.6951,0001,157,430118,454Apr 09 06:04 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyApr 07Option Exercise24.7448,6531,203,675176,448Apr 09 04:29 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyApr 07Sale38.0448,6531,850,570127,795Apr 09 04:29 PM
BAY MOGENS CDirectorApr 07Sale37.9630,4951,157,65187,959Apr 09 06:04 PM
Gehring JohnEVP and CFOApr 06Option Exercise23.93160,0003,828,800207,427Apr 07 04:37 PM
Gehring JohnEVP and CFOApr 06Sale37.96160,0006,074,35247,427Apr 07 04:37 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 02Option Exercise26.1530,000784,500130,943Apr 03 02:29 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 02Sale37.5030,0001,125,000100,943Apr 03 02:29 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerMar 31Option Exercise23.45220,0005,159,600268,562Apr 01 04:52 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerMar 31Sale36.73220,0008,080,88648,562Apr 01 04:52 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryMar 30Option Exercise23.9345,0001,076,850145,943Apr 01 04:47 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryMar 30Sale36.5645,0001,645,173100,943Apr 01 04:47 PM
Wise Robert GSVP, Corporate ControllerJan 17Option Exercise0.005,000015,617Jan 20 04:41 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 06Option Exercise24.7424,800613,55269,280Jan 07 04:33 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 06Sale35.2224,800873,45144,480Jan 07 04:33 PM
McGough Thomas MPresident, Consumer FoodsJan 05Option Exercise23.9011,236268,54060,388Jan 06 05:21 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 05Option Exercise25.32190,0004,810,580253,060Jan 06 05:26 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryJan 05Option Exercise23.9315,000358,950115,943Jan 07 04:32 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 05Option Exercise24.7411,200277,08855,680Jan 07 04:33 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 05Sale35.6111,200398,82944,480Jan 07 04:33 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryJan 05Sale35.6015,000534,024100,943Jan 07 04:32 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 05Sale35.66190,0006,775,30563,060Jan 06 05:26 PM
McGough Thomas MPresident, Consumer FoodsJan 05Sale35.948,779315,50051,609Jan 06 05:21 PM
McGough Thomas MPresident, Consumer FoodsJan 02Option Exercise19.5911,264220,71057,052Jan 06 05:21 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 02Option Exercise22.90202,0004,626,300265,060Jan 06 05:26 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 02Sale36.03202,0007,278,34363,060Jan 06 05:26 PM
McGough Thomas MPresident, Consumer FoodsJan 02Sale36.157,900285,54849,152Jan 06 05:21 PM
Wise Robert GSVP, Corporate ControllerDec 23Option Exercise23.906,600157,74017,217Dec 23 04:28 PM
Wise Robert GSVP, Corporate ControllerDec 23Sale36.906,600243,54510,617Dec 23 04:28 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyDec 22Option Exercise24.80198,0004,911,300303,795Dec 23 04:21 PM
Gehring JohnEVP and CFODec 22Option Exercise21.10160,0003,375,200207,427Dec 23 04:25 PM
Gehring JohnEVP and CFODec 22Sale36.82160,0005,891,52047,427Dec 23 04:25 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyDec 22Sale36.58176,0006,438,925127,795Dec 23 04:21 PM
McGough Thomas MPresident, Consumer FoodsNov 28Option Exercise19.055,00095,25049,197Dec 02 04:28 PM
McGough Thomas MPresident, Consumer FoodsNov 28Sale36.003,409122,72445,788Dec 02 04:28 PM
McGough Thomas MPresident, Consumer FoodsNov 18Option Exercise19.055,00095,25047,657Nov 20 04:50 PM
McGough Thomas MPresident, Consumer FoodsNov 18Sale35.003,460121,10044,197Nov 20 04:50 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerSep 24Option Exercise21.26120,0002,551,200168,562Sep 26 04:29 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerSep 24Sale33.44120,0004,013,24448,562Sep 26 04:29 PM
McGough Thomas MPresident, Consumer FoodsSep 23Option Exercise21.266,900146,69447,898Sep 24 05:20 PM
McGough Thomas MPresident, Consumer FoodsSep 23Sale33.135,241173,63442,657Sep 24 05:20 PM
McGough Thomas MPresident, Consumer FoodsSep 22Option Exercise21.263,10065,90640,998Sep 24 05:20 PM
GILD Gilead Sciences Inc. daily Stock Chart
GILD [NASD]
Gilead Sciences Inc.
IndexS&P 500 P/E13.40 EPS (ttm)8.80 Insider Own0.50% Shs Outstand1.47B Perf Week0.20%
Market Cap173.27B Forward P/E10.59 EPS next Y11.13 Insider Trans-18.46% Shs Float1.46B Perf Month0.70%
Income14.21B PEG0.65 EPS next Q2.70 Inst Own85.70% Short Float1.41% Perf Quarter17.73%
Sales27.49B P/S6.30 EPS this Y306.10% Inst Trans0.06% Short Ratio1.86 Perf Half Y13.58%
Book/sh11.55 P/B10.21 EPS next Y2.61% ROA42.70% Target Price124.47 Perf Year26.16%
Cash/sh7.69 P/C15.34 EPS next 5Y20.60% ROE91.30% 52W Range85.64 - 123.37 Perf YTD25.53%
Dividend1.72 P/FCF10.54 EPS past 5Y39.10% ROI44.80% 52W High-4.43% Beta0.79
Dividend %1.46% Quick Ratio2.40 Sales past 5Y28.80% Gross Margin86.00% 52W Low37.67% ATR2.83
Employees7000 Current Ratio2.70 Sales Q/Q51.90% Oper. Margin64.00% RSI (14)55.57 Volatility3.55% 2.13%
OptionableYes Debt/Eq0.72 EPS Q/Q107.50% Profit Margin51.70% Rel Volume1.08 Prev Close115.71
ShortableYes LT Debt/Eq0.69 EarningsJul 28 AMC Payout4.60% Avg Volume11.10M Price117.90
Recom2.00 SMA202.01% SMA501.92% SMA20011.74% Volume11,942,082 Change1.89%
Jul-29-15Reiterated RBC Capital Mkts Outperform $120 → $130
Jul-29-15Reiterated Piper Jaffray Overweight $131 → $134
Jul-29-15Reiterated Oppenheimer Outperform $86 → $120
Jul-29-15Reiterated Needham Buy $120 → $125
Jul-29-15Reiterated Maxim Group Buy $127 → $129
Jul-29-15Reiterated Deutsche Bank Buy $125 → $135
Jul-29-15Reiterated Barclays Overweight $125 → $130
Jul-24-15Reiterated Piper Jaffray Overweight $120 → $131
Jun-23-15Reiterated Argus Buy $130 → $150
May-01-15Reiterated RBC Capital Mkts Outperform $118 → $120
May-01-15Reiterated Piper Jaffray Overweight $116 → $120
Feb-04-15Reiterated RBC Capital Mkts Outperform $125 → $118
Dec-23-14Reiterated Deutsche Bank Buy $142 → $125
Dec-09-14Reiterated Argus Buy $110 → $130
Oct-29-14Reiterated RBC Capital Mkts Outperform $115 → $125
Oct-13-14Reiterated FBR Capital Outperform $125 → $130
Sep-25-14Reiterated Needham Buy $95 → $120
Aug-22-14Reiterated RBC Capital Mkts Outperform $102 → $115
Aug-15-14Initiated FBR Capital Outperform $125
Aug-11-14Reiterated Argus Buy $90 → $110
Jul-30-15 09:39PM  No Rush to Hop on M&A Bandwagon, Says Gilead Sciences CFO at The Wall Street Journal
02:52PM  Even With Recent Declines, Investors Still Love Biotech ETFs
10:02AM  Gilead Wont Run Out of Hep C Patients, or Dollars, Anytime Soon at Bloomberg
10:02AM  Gilead Won't Run Out of Hep C Patients, or Dollars, Anytime Soon
09:30AM  The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press Releases
09:10AM  Nearing Retirement? These Are the 8 Stocks Retirees Should Own at Kiplinger
08:04AM  Gilead's Hepatitis C Dominance Unchecked By AbbVie at Motley Fool
12:10AM  Gilead: the Apple of the Biotech World at The Wall Street Journal
Jul-29-15 07:45PM  Gilead hepatitis C drugs build road to Japan at bizjournals.com
04:51PM  U.S. stocks end higher as Fed leaves September hike on the table at MarketWatch
02:47PM  Q2 Earnings Season Halftime Report
02:37PM  5 Big Stocks on Traders' Radars -- and What You Should Do With Them Now at TheStreet
02:10PM  Here are all the Boston-area biotechs about to buy or get bought at bizjournals.com
01:52PM  Gilead in Go-Go Mode as Profits, Forecast Impress at Barrons.com
01:27PM  Should Gilead Really Be Rated Underperform? at 24/7 Wall St.
12:33PM  Gilead Sciences, Inc. -- Moody's: Gilead's hepatitis-C sales continue strong streak at Moody's
12:29PM  Gilead Gets Wall Street Love After Q2 Earnings Beat at Investor's Business Daily
12:27PM  4 Stocks, 4 trades: Gilead, Altria & more
12:24PM  Dow adds 100 points as Street awaits Fed statement; earnings eyed at CNBC
11:37AM  Twitter, Yelp sink to 52-week low; Citrix jumps on strong results at MarketWatch
11:02AM  Four Reasons Gilead Can Head Higher at Barrons.com
10:35AM  Cramer -- Gilead Has a Fabulous Quarter, Tons of Merger Opportunities at TheStreet
10:34AM  Gilead Sciences: Here's What A Bull And A Bear Are Saying
10:07AM  Is Biotech a Bubble? Gilead Sciences Doesn't Think So at Barrons.com
09:41AM  Amp Up Your Portfolio With These Biotech Stocks at Motley Fool
09:40AM  Gilead (GILD) Beats on Q2 Earnings, Raises 2015 Outlook - Analyst Blog
09:30AM  Lithia Motors, Qualcomm, Twitter, Gilead and Facebook highlighted as Zacks Bull and Bear of the Day - Press Releases
09:23AM  Cramer's Mad Dash: Hats off to Gilead
09:04AM  Gilead Sciences (GILD) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
09:00AM  Twitter warning; Anthem gains; MasterCard dollar woes
08:54AM  Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More at 24/7 Wall St.
08:14AM  Focus on Fed; Twitter's big blow; Facebook's politics plunge
07:54AM  Early movers: HLT, ANTM, ETN, TWTR, GSK & more at CNBC
07:46AM  Get ready to cash in on the bottom for commodities at MarketWatch
07:40AM  Top 10 New Stocks to Trade Like Hedge Fund Renaissance Technologies at TheStreet
07:28AM  US STOCKS-U.S. futures higher ahead of Fed statement
03:58AM  Edited Transcript of GILD earnings conference call or presentation 28-Jul-15 8:30pm GMT
Jul-28-15 09:53PM  How a hugely overpriced hepatitis drug helped drive up U.S. health spending at Los Angeles Times
08:07PM  5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen at Investor's Business Daily
06:53PM  Gilead Lifts Sales View As Hep C Drugs Top
06:47PM  Gilead beats Street 2Q forecasts on surge in sales, profit
06:41PM  Gilead hepatitis C sales beat Wall Street, sales outlook raised
06:27PM  Gilead beats Street's 2Q forecasts on surge in sales, profit at San Jose Mercury News
06:00PM  Google, Amazon And Microsoft Curb Spending To Boost Profits
05:58PM  Fast Money Final Trade: GILD, TWTR & YELP
05:51PM  Pricey hepatitis C drugs help Gilead eclipse big sales threshold at bizjournals.com
05:36PM  Twitter Q2 Earnings Turns After-hours Rollercoaster - Analyst Blog
05:20PM  Gilead Sciences Inc. Posts Q2 Results, Able to Beat Earnings, Revenue Estimates - Stocks in the News
05:14PM  Gilead Sciences Inc. Q2 Earnings: Harvoni Delivers Again at Motley Fool
05:12PM  Gilead higher after earnings beat
05:03PM  Express Scripts Raises Guidance as Earnings Top Views at The Wall Street Journal
04:54PM  Twitter soars on strong results; Yelp tanks at MarketWatch
04:54PM  Gilead Tops Estimates in 2Q
04:48PM  Gilead Sciences (GILD) Stock Climbing in After Hours Trading Following Earnings Results at TheStreet
04:34PM  Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds at Investor's Business Daily
04:30PM  Gilead Sciences Inc Earnings Call scheduled for 4:30 pm ET today
04:28PM  Stocks Pop As China Losses Lessen, Fed Comes Into Focus at Barrons.com
04:23PM  Gilead 2nd-quarter profit increases 32 pct, 2015 outlook raised
04:22PM  Gilead Sales Soar on Hepatitis Drugs at The Wall Street Journal
04:21PM  Gilead Sciences: 'Appears to Be an Awesome Quarter' at Barrons.com
04:16PM  Gilead rallies after earnings beat Wall Street's expectations at MarketWatch
04:15PM  Gilead beats Street 2Q forecasts
04:15PM  Gilead Q2 Earnings: KAPOW! BAM! BOOM! (Yes, That Good) at TheStreet
04:04PM  GILEAD SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
04:03PM  Gilead Profit Tops Estimates as Hepatitis C Drug Sales Surge at Bloomberg
04:02PM  Gilead Sciences Announces Third Quarter 2015 Dividend Business Wire
04:01PM  Gilead Sciences Announces Second Quarter 2015 Financial Results Business Wire
02:31PM  3 stocks for retirees to buy at USA TODAY
01:33PM  Gilead Sciences: How Will the Market React to Slowing U.S. Hep-C Sales? at Barrons.com
01:18PM  Is More M&A On The Way For Large-Cap Biotechs?
01:13PM  5 Health Care Stocks to Trade for Gains -- Must-See Charts at TheStreet
12:59PM  Halftime's hottest trades: Earnings plays
12:58PM  Top trades for the 2nd half: ESRX, MA & GILD
10:35AM  Biogens 2Q15 Earnings Beat Wall Street Estimates
10:02AM  Wait, Will Allergan Really Buy Biogen or Amgen? at Barrons.com
09:30AM  The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmaceuticals and Express Scripts - Press Releases
08:00AM  Biotech darling Gilead to pale in comparison to previous quarters: Estimize
07:42AM  Are These 2 Big Pharmas Really Buyout Candidates? at Motley Fool
07:07AM  Q2 2015 Gilead Sciences Inc Earnings Release - 4:05 pm ET
07:03AM  3 Big Biotech Buybacks That Investors Should Love at Motley Fool
06:31AM  Merck Targets Toughest Cases for Foothold in Hepatitis C Market at Bloomberg
Jul-27-15 08:15PM  Fed Meeting, Twitter Earnings, Consumer Data in Focus Tuesday at TheStreet
07:03PM  3 Stocks for Retirees to Buy at Motley Fool
06:46PM  Which Big-Cap Stocks Are Defying Market Pressure? at Investor's Business Daily
05:16PM  Gilead Sciences: Sure, It's Hep-C But It's Not Just Hep-C at Barrons.com
04:30PM  Gilead Announces Executive Promotions Business Wire
04:30PM  Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash at TheStreet
04:12PM  Wall Street's Best Think Gilead Will Continue To Outperform The Market
03:24PM  Is Gilead Sciences About to Make an Acquisition?
02:52PM  What to Watch in the Day Ahead - Tuesday, July 28 Reuters
02:37PM  The Incredible Gilead Faces Its Moment of Truth
12:42PM  Gilead Can Soothe Biotech Investor Fears with Great 2Q Earnings at TheStreet
10:30AM  5 Stocks to Watch for this Week 7/27
10:06AM  Whats Gileads Deal? Cash Burns Hole in Investors Pockets at Bloomberg
07:57AM  Short Sellers Back Off Major Biotechs at 24/7 Wall St.
Jul-26-15 09:40PM  This Healthcare Fund Thinks Large-Caps Are The Best Way To Go at Insider Monkey
05:21PM  The Only Six Stocks That Matter at The Wall Street Journal
12:15PM  [video]What to Watch in the Week Ahead: Twitter, Facebook Earnings, GDP at TheStreet
10:21AM  BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead at 24/7 Wall St.
Jul-25-15 07:07AM  1 ETF Thats Crushing Even Warren Buffett at Motley Fool
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. The company's products include Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver disease. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaborations with Bristol-Myers Squibb Company, Janssen R&D Ireland, and Japan Tobacco Inc. to develop and commercialize various products. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BISCHOFBERGER NORBERT WEVP, R&D and CSOJul 15Option Exercise21.5870,0001,510,250235,168Jul 17 03:57 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJul 15Sale118.2066,2617,832,152168,907Jul 17 03:57 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJul 07Sale119.393,739446,400165,168Jul 17 03:57 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Option Exercise26.993,00080,97050,632Jul 06 04:00 PM
Alton Gregg HEVP, Corp & Med AffairsJul 01Option Exercise23.7615,000356,325156,422Jul 06 04:01 PM
MARTIN JOHN CChairman and CEOJul 01Option Exercise14.50150,0002,175,3754,364,492Jul 06 04:02 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Sale118.243,000354,72947,632Jul 06 04:00 PM
Alton Gregg HEVP, Corp & Med AffairsJul 01Sale116.7317,0001,984,446139,422Jul 06 04:01 PM
MARTIN JOHN CChairman and CEOJul 01Sale116.46150,00017,469,6614,214,492Jul 06 04:02 PM
Cogan John FrancisDirectorJun 26Option Exercise14.3412,000172,08056,309Jun 30 07:32 PM
Cogan John FrancisDirectorJun 26Sale120.1327,0003,243,42144,309Jun 30 07:32 PM
Carter Paul RutherfordEVP Commercial OpsJun 18Option Exercise26.9910,000269,90057,632Jun 22 04:17 PM
Carter Paul RutherfordEVP Commercial OpsJun 18Sale120.0010,0001,200,02547,632Jun 22 04:17 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJun 15Option Exercise21.5870,0001,510,250235,168Jun 17 07:25 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJun 15Sale117.6770,0008,237,002165,168Jun 17 07:25 PM
MILLIGAN JOHN FPresident and COOJun 08Option Exercise14.50100,0001,450,2501,129,108Jun 10 01:03 PM
MILLIGAN JOHN FPresident and COOJun 08Sale114.05100,00011,405,4131,029,108Jun 10 01:03 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Option Exercise34.713,000104,12050,632Jun 03 06:07 PM
MARTIN JOHN CChairman and CEOJun 01Option Exercise14.50150,0002,175,3754,405,876Jun 03 06:07 PM
Alton Gregg HEVP, Corp & Med AffairsJun 01Option Exercise23.7115,000355,647158,422Jun 03 06:07 PM
MARTIN JOHN CChairman and CEOJun 01Sale113.95150,00017,092,3444,255,876Jun 03 06:07 PM
Alton Gregg HEVP, Corp & Med AffairsJun 01Sale113.6417,0001,931,891141,422Jun 03 06:07 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Sale113.093,000339,27847,632Jun 03 06:07 PM
Carter Paul RutherfordEVP Commercial OpsMay 15Option Exercise67.786,000406,68753,632May 19 07:24 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOMay 15Option Exercise21.3470,0001,493,550235,168May 19 07:25 PM
Alton Gregg HEVP, Corp & Med AffairsMay 15Option Exercise19.2025,000479,947168,422May 19 07:25 PM
Carter Paul RutherfordEVP Commercial OpsMay 15Sale110.006,000660,02047,632May 19 07:24 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOMay 15Sale109.4570,0007,661,533165,168May 19 07:25 PM
Alton Gregg HEVP, Corp & Med AffairsMay 15Sale110.0125,0002,750,210143,422May 19 07:25 PM
Carter Paul RutherfordEVP Commercial OpsMay 10Option Exercise0.005,000050,439May 12 06:02 PM
MILLIGAN JOHN FPresident and COOMay 07Option Exercise14.50100,0001,450,2501,129,108May 11 08:24 PM
MILLIGAN JOHN FPresident and COOMay 07Sale101.00100,00010,100,1621,029,108May 11 08:24 PM
Whitley Richard JamesDirectorMay 05Option Exercise19.6321,720426,36437,361May 07 05:14 PM
Alton Gregg HEVP, Corp & Med AffairsMay 01Option Exercise19.0910,000190,850155,422May 05 07:38 PM
Carter Paul RutherfordEVP Commercial OpsMay 01Option Exercise80.652,000161,30047,439May 05 04:23 PM
MARTIN JOHN CChairman and CEOMay 01Option Exercise14.50150,0002,175,3754,405,876May 05 05:47 PM
Washington Robin LEVP, CFOMay 01Option Exercise29.7016,842500,13044,566May 05 07:38 PM
MARTIN JOHN CChairman and CEOMay 01Sale104.95150,00015,742,4914,255,876May 05 05:47 PM
Carter Paul RutherfordEVP Commercial OpsMay 01Sale103.182,000206,36545,439May 05 04:23 PM
Alton Gregg HEVP, Corp & Med AffairsMay 01Sale104.0712,0001,248,871143,422May 05 07:38 PM
Washington Robin LEVP, CFOMay 01Sale105.0616,8421,769,40527,724May 05 07:38 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOApr 15Option Exercise20.7470,0001,451,800235,168Apr 17 02:23 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOApr 15Sale103.8470,0007,268,627165,168Apr 17 02:23 PM
Alton Gregg HEVP, Corp & Med AffairsApr 08Option Exercise19.095,00095,425150,422Apr 09 04:40 PM
Carter Paul RutherfordEVP Commercial OpsApr 08Option Exercise80.651,00080,65046,439Apr 09 04:40 PM
Alton Gregg HEVP, Corp & Med AffairsApr 08Sale100.005,000500,000145,422Apr 09 04:40 PM
Carter Paul RutherfordEVP Commercial OpsApr 08Sale100.001,000100,00045,439Apr 09 04:40 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Option Exercise80.651,00080,65046,439Apr 03 05:24 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Option Exercise19.095,00095,425152,422Apr 03 05:24 PM
MARTIN JOHN CChairman and CEOApr 01Option Exercise14.50150,0002,175,3754,405,876Apr 03 05:24 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Sale96.537,000675,715145,422Apr 03 05:24 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Sale98.041,00098,04445,439Apr 03 05:24 PM
MARTIN JOHN CChairman and CEOApr 01Sale96.74150,00014,511,4634,255,876Apr 03 05:24 PM
Whitley Richard JamesDirectorMar 02Option Exercise26.995,000134,95020,641Mar 03 04:12 PM
Alton Gregg HEVP, Corp & Med AffairsMar 02Option Exercise19.0910,000190,850159,422Mar 04 07:49 PM
MARTIN JOHN CChairman and CEOMar 02Option Exercise14.50150,0002,175,3754,405,876Mar 04 07:48 PM
Carter Paul RutherfordEVP Commercial OpsMar 02Option Exercise80.652,000161,30047,439Mar 04 07:49 PM
Carter Paul RutherfordEVP Commercial OpsMar 02Sale104.182,000208,36445,439Mar 04 07:49 PM
MARTIN JOHN CChairman and CEOMar 02Sale103.51150,00015,526,2454,255,876Mar 04 07:48 PM
Alton Gregg HEVP, Corp & Med AffairsMar 02Sale103.6312,0001,243,615147,422Mar 04 07:49 PM
Whitley Richard JamesDirectorMar 02Sale103.435,000517,13615,641Mar 03 04:12 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOFeb 17Option Exercise16.4070,0001,147,650235,168Feb 19 06:42 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOFeb 17Sale103.0170,0007,210,740165,168Feb 19 06:42 PM
WOLD OLSEN PERDirectorFeb 06Buy99.9210,000999,15088,173Feb 10 04:30 PM
MARTIN JOHN CChairman and CEOFeb 02Option Exercise14.50150,0002,175,3754,272,987Feb 04 08:15 PM
Washington Robin LEVP, CFOFeb 02Option Exercise25.1433,192834,58683,024Feb 04 08:52 PM
Alton Gregg HEVP, Corp & Med AffairsFeb 02Option Exercise19.0910,000190,850123,694Feb 04 08:51 PM
Carter Paul RutherfordEVP Commercial OpsFeb 02Option Exercise80.652,000161,30036,308Feb 04 08:52 PM
Whitley Richard JamesDirectorFeb 02Option Exercise26.995,000134,95020,641Feb 04 04:04 PM
MARTIN JOHN CChairman and CEOFeb 02Sale105.43150,00015,815,2494,122,987Feb 04 08:15 PM
Washington Robin LEVP, CFOFeb 02Sale105.3833,1923,497,66249,832Feb 04 08:52 PM
Alton Gregg HEVP, Corp & Med AffairsFeb 02Sale105.7312,0001,268,719111,694Feb 04 08:51 PM
Carter Paul RutherfordEVP Commercial OpsFeb 02Sale106.152,000212,31034,308Feb 04 08:52 PM
Whitley Richard JamesDirectorFeb 02Sale105.675,000528,35815,641Feb 04 04:04 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJan 15Option Exercise16.4070,0001,147,650189,302Jan 20 12:46 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJan 15Sale98.4770,0006,893,083119,302Jan 20 12:46 PM
Carter Paul RutherfordEVP Commercial OpsJan 08Option Exercise36.721,00036,72035,308Jan 12 03:55 PM
Carter Paul RutherfordEVP Commercial OpsJan 08Sale100.881,000100,88134,308Jan 12 03:55 PM
MARTIN JOHN CChairman and CEOJan 05Sale96.651009,6654,122,987Jan 06 04:20 PM
Carter Paul RutherfordEVP Commercial OpsJan 02Option Exercise40.561,00040,56035,308Jan 06 04:21 PM
MARTIN JOHN CChairman and CEOJan 02Option Exercise14.50150,0002,175,3754,272,987Jan 06 04:20 PM
Whitley Richard JamesDirectorJan 02Option Exercise26.995,000134,95020,641Jan 06 02:12 PM
Alton Gregg HEVP, Corp & Med AffairsJan 02Option Exercise19.095,00095,425120,694Jan 06 04:20 PM
Whitley Richard JamesDirectorJan 02Sale95.225,000476,10015,641Jan 06 02:12 PM
MARTIN JOHN CChairman and CEOJan 02Sale95.11149,90014,257,7224,123,087Jan 06 04:20 PM
Alton Gregg HEVP, Corp & Med AffairsJan 02Sale95.177,000666,192113,694Jan 06 04:20 PM
Carter Paul RutherfordEVP Commercial OpsJan 02Sale95.051,00095,05034,308Jan 06 04:21 PM
Cogan John FrancisDirectorDec 22Option Exercise14.3426,000372,77568,405Dec 24 12:58 PM
Cogan John FrancisDirectorDec 22Sale95.0326,0002,470,75542,405Dec 24 12:58 PM
MILLIGAN JOHN FPresident and COODec 08Option Exercise8.01146,8231,175,3181,120,871Dec 10 05:32 PM
MILLIGAN JOHN FPresident and COODec 08Sale106.26146,82315,601,122974,048Dec 10 05:32 PM
MARTIN JOHN CChairman and CEODec 01Option Exercise8.01140,6331,125,7674,263,620Dec 03 07:13 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Option Exercise40.562,00081,12036,308Dec 03 07:14 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Option Exercise24.2931,000752,947149,694Dec 03 07:13 PM
Whitley Richard JamesDirectorDec 01Option Exercise26.995,000134,95020,641Dec 03 03:46 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Sale100.022,000200,03134,308Dec 03 07:14 PM
MARTIN JOHN CChairman and CEODec 01Sale100.72140,63314,164,8294,122,987Dec 03 07:13 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Sale100.7933,0003,325,922116,694Dec 03 07:13 PM
Whitley Richard JamesDirectorDec 01Sale100.195,000500,96915,641Dec 03 03:46 PM
Cogan John FrancisDirectorNov 21Option Exercise14.3425,000358,43867,405Nov 25 04:10 PM
V Visa Inc. daily Stock Chart
V [NYSE]
Visa Inc.
IndexDJIA S&P500 P/E30.19 EPS (ttm)2.53 Insider Own0.10% Shs Outstand2.43B Perf Week6.45%
Market Cap185.82B Forward P/E25.69 EPS next Y2.97 Insider Trans-0.66% Shs Float2.31B Perf Month13.75%
Income5.87B PEG1.67 EPS next Q0.73 Inst Own92.90% Short Float2.64% Perf Quarter15.84%
Sales13.54B P/S13.73 EPS this Y13.20% Inst Trans0.23% Short Ratio8.65 Perf Half Y23.63%
Book/sh13.78 P/B5.54 EPS next Y15.46% ROA15.10% Target Price80.85 Perf Year43.79%
Cash/sh1.94 P/C39.35 EPS next 5Y18.08% ROE20.90% 52W Range48.53 - 76.92 Perf YTD16.94%
Dividend0.48 P/FCF37.11 EPS past 5Y25.20% ROI19.70% 52W High-0.70% Beta0.65
Dividend %0.63% Quick Ratio1.70 Sales past 5Y12.90% Gross Margin- 52W Low57.39% ATR1.34
Employees9500 Current Ratio1.70 Sales Q/Q11.50% Oper. Margin64.90% RSI (14)74.16 Volatility2.22% 1.50%
OptionableYes Debt/Eq0.00 EPS Q/Q46.30% Profit Margin43.40% Rel Volume0.91 Prev Close76.01
ShortableYes LT Debt/Eq0.00 EarningsJul 23 AMC Payout18.00% Avg Volume7.04M Price76.38
Recom1.90 SMA208.10% SMA509.76% SMA20016.42% Volume6,382,401 Change0.49%
Jul-24-15Reiterated Topeka Capital Markets Hold $66 → $70
Jul-24-15Reiterated RBC Capital Mkts Outperform $79 → $82
Jul-24-15Reiterated FBR Capital Mkt Perform $70 → $80
Jul-20-15Reiterated Oppenheimer Outperform $73 → $81
Jul-14-15Reiterated Bernstein Outperform $77 → $81
May-20-15Initiated Credit Agricole Outperform $77
Jan-30-15Reiterated Stifel Buy $280 → $308
Jan-30-15Reiterated Argus Buy $295 → $300
Jan-30-15Downgrade FBR Capital Outperform → Mkt Perform $260
Jan-23-15Reiterated Oppenheimer Outperform $250 → $290
Dec-08-14Reiterated Argus Buy $260 → $295
Nov-12-14Initiated Topeka Capital Markets Hold $261
Oct-31-14Upgrade Argus Hold → Buy $260
Oct-30-14Upgrade FBR Capital Mkt Perform → Outperform $250 → $260
Oct-30-14Reiterated Stifel Buy $281 → $280
Oct-24-14Reiterated Oppenheimer Outperform $270 → $250
Apr-25-14Reiterated RBC Capital Mkts Outperform $263 → $250
Apr-14-14Upgrade Robert W. Baird Neutral → Outperform $245
Apr-14-14Initiated Pacific Crest Outperform $241
Jan-31-14Reiterated FBR Capital Mkt Perform $210 → $250
Jul-30-15 02:51PM  Why MasterCard Couldn't Be Happier About Visa's $15 Billion European Megadeal at TheStreet
02:13PM  A "Long" Look At FireEye at Forbes
12:32PM  How Americans Pay: Study Shows Shoppers Still Pick Cash, Check Over PayPal, Apple Pay at Forbes
12:25PM  Why Pepsi, Time Warner Should Be in Your Portfolio at TheStreet
12:16PM  Many US retailers not ready for fraud-proof cards at CNBC
08:58AM  3 Reasons Why Visa (V) Is a Great Growth Stock - Tale of the Tape
Jul-29-15 05:33PM  Merchants seek to void $6 billion Visa, MasterCard, AmEx settlements
05:31PM  Merchants seek to void $6 bln Visa, MasterCard, AmEx settlements Reuters
01:31PM  Stocks Higher As Fed Statement Looms; Verisk Breaks Out at Investor's Business Daily
01:04PM  VISA INC. Financials
01:00PM  FireEye (FEYE) to Report Q2 Earnings: What to Expect? - Analyst Blog
11:47AM  PayPal Faces New Threat as Visa Partners With Payments Startup Stripe at TheStreet
11:36AM  Visa's Buyback May Grow Big-Time After $15 Billion Deal - What Jim Cramer Thinks at TheStreet
11:21AM  MasterCard Hit By Strong Dollar, Misses Sales at Investor's Business Daily
11:11AM  AmEx Plaintiffs Say E-Mails Shouldnt Block Antitrust Accord at Bloomberg
09:36AM  MasterCard 2Q profit slips and revenue falls short
09:20AM  MasterCard 2Q misses on revenue
09:20AM  MasterCard Revenue Falls Short of Estimates on Strong Dollar
08:11AM  MasterCard Profit Meets Analyst Estimates as Expenses Climb at Bloomberg
08:09AM  MasterCard's quarterly profit falls as costs rise Reuters
01:22AM  What would you buy: Germany's DAX or Apple? at CNBC
Jul-28-15 04:12PM  Why Visa Is Investing in Stripe
04:04PM  Stripe inks deal with Visa, officially hits $5 billion valuation at bizjournals.com
02:20PM  Stripe partners with Visa, leaping to $5B value with new funding at bizjournals.com
02:20PM  Buy Visa On Hopes Of Visa Europe Deal: Macquarie at Barrons.com
01:42PM  Apple Pay Partner Stripe Gets $5 Billion Valuation at Investor's Business Daily
01:32PM  Friendly Lawyers May Scuttle $6 Billion Visa Deal at Investor's Business Daily
01:12PM  Visa Invests in Payments Provider Stripe
01:12PM  Visa Invests in Payments Provider Stripe at $5 Billion Valuation at Bloomberg
12:00PM  Visa and Stripe Partner to Expand Online Commerce Globally Business Wire
11:00AM  FIDO Authentication Gains Momentum in US and European Financial Services Marketwired
09:06AM  Leading Economic Index Indicates Steady Growth in the US
09:00AM  Visa® and Orbitz for Business® to Offer Fully Integrated Business Travel and Expense Solution Business Wire
07:50AM  Online payments startup Stripe raises new funds at $5 billion valuation at MarketWatch
06:00AM  Visa and Mastercard settlement in jeopardy
02:03AM  Payments Startup Stripe Raises Funds at $5 Billion Valuation at The Wall Street Journal
12:00AM  Stripes new funding makes it a $5 billion company at Fortune
Jul-27-15 06:11PM  Lawyer emails threaten $6B settlement: Report at CNBC
09:28AM  Falling Jobless Claims Suggest a Strengthening Labor Market
09:28AM  Utilities and Mining Drove the CFNAI Up in June: SPY Falls 1.04%
08:23AM  Visa Due for a Pullback After Surging Post-Earnings at TheStreet
Jul-26-15 10:53AM  Visa And Three Other Dow Stocks With Up Or Down Moves Of More Than 10% In July at Forbes
10:30AM  7 reasons some shoppers hate Costco at MarketWatch
10:30AM  7 reasons some shoppers hate Costco
Jul-25-15 08:09PM  10-Q for Visa, Inc. at Company Spotlight
05:34PM  Smart Money Had It Right As Visa (V) Beats On Earnings at Insider Monkey
Jul-24-15 06:43PM  New High Analysis: Insurer Clears Cup-With-Handle Base at Investor's Business Daily
04:51PM  U.S. Stocks Tumble
04:28PM  Square confidentially files for IPO: Report at CNBC
04:16PM  Backpage.com Wins Restraining Order Against Cook County Sheriff at Forbes
04:12PM  Visa Charges Higher As Card Peers Fall On Earnings
04:10PM  Visa Shares Soar on Rumors of Merger with Visa Europe - Analyst Blog
04:04PM  Stocks Suffer Deep Weekly Losses on Oil, Earnings at TheStreet
03:59PM  Money Minute: 5 credit card perks you never knew you had
03:01PM  Major Indexes Extend Losses; Sucampo Bucks Weakness at Investor's Business Daily
02:58PM  Stocks Extend Losses as Crude Suffers Weekly Loss at TheStreet
02:30PM  Street Talk: SCTY, V, BIDU & GILD
12:23PM  4 Stocks, 4 trades: Pandora, AT&T and more
11:41AM  Trending Now: V
11:37AM  Visa: Resilience at Barrons.com
11:30AM  Amazon reaches clouds; Visa charges up; AT&T, DirecTV deal to be ok'd
10:52AM  Stocks lower amid data; Amazon jumps at CNBC
10:48AM  Stocks Extend Losses; Anthem, Cigna Fall on Merger News at TheStreet
10:39AM  Stocks Open Mixed And Wild; Maxim, Visa, Amazon Spike at Investor's Business Daily
10:30AM  U.S. stocks turn lower, weekly loss looms at MarketWatch
09:48AM  Visa Surges on Talks to Acquire European Counterpart This Year at Bloomberg
09:36AM  US STOCKS SNAPSHOT-US stocks open lower after mixed bag of earnings
09:10AM  Visa Beats Q3 Earnings & Revenue Estimates, Affirms View - Analyst Blog
09:09AM  Stock Futures Up, Trimming Gains; Amazon, Visa, Starbucks Rally at Investor's Business Daily
09:02AM  Amazon takes off; Starbucks' big quarter; Biogen warns
08:40AM  Stock Futures Edge Higher as Amazon Soars at TheStreet
08:35AM  FIFA to meet sponsors after reproaches from Coke, Visa, McDonald's
08:12AM  Visa (V) Stock Rallying After Earnings Beat at TheStreet
08:08AM  'Nifty' growth stocks keep the bears at bay, for now
07:54AM  Early movers: CI, AMZN, SAVE, BIIB, MCO, T & more at CNBC
07:44AM  July 24 Premarket Briefing: 10 Things You Should Know
07:37AM  Blue Chip Bust as Dow Trails S&P Most Since 2009 on Earnings at Bloomberg
07:29AM  Visa (V) Earnings Report: Q3 2015 Conference Call Transcript at TheStreet
06:23AM  Advertising's digital challenge: Sir Martin Sorrell
05:00AM  Amazon, Starbucks Continue to Impress Wall Street at TheStreet
04:50AM  U.S. Stock-Index Futures Advance Following Amazon, Visa Earnings at Bloomberg
01:11AM  FIFA sponsor Visa calls for independent reform board
12:07AM  Edited Transcript of V earnings conference call or presentation 23-Jul-15 9:00pm GMT
Jul-23-15 08:45PM  Visa Says FIFA Needs New Leadership Amid Bribery Investigations at Bloomberg
08:08PM  Visa adds to pressure for Blatter exit at Financial Times
07:52PM  Visa Inc. Crushes Wall Streets Earnings Expectations While Continuing to Gush Cash at Motley Fool
06:37PM  Visa joins Coke in call for independent body to reform FIFA
06:25PM  Visa CEO Blasts FIFA's Response to Corruption Scandal at The Wall Street Journal
06:16PM  Visa 3Q earnings jump 25 percent, beat estimates
05:57PM  After-hours buzz: Amazon, Pandora, Visa & more at CNBC
05:42PM  Visa Able to Beat on Earnings and Revenues, Sees Stock Price Jump After Hours - Stocks in the News
05:40PM  Final grades on earnings
05:06PM  Stocks Extend Losses; Amazon, Visa Headline After-Hours Action at Investor's Business Daily
05:02PM  Visa Crushes Q3 Earnings Estimates; Shares Jump Late at Investor's Business Daily
05:01PM  Visa: Now That's a Beat at Barrons.com
04:58PM  Why Visa's Big Earnings Beat Could Lead Apple Shares To $200
04:52PM  US STOCKS-Wall St falls for 3rd day as earnings fall short
04:40PM  Visa shares rally on strong results at MarketWatch
04:38PM  Visa Easily Tops Earnings Estimates, Says In Talks With Visa Europe at Forbes
04:36PM  Visa fiscal 3Q earnings jump 25 percent
Visa Inc., a payments technology company, operates as a retail electronic payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. It owns and operates VisaNet that is involved in the authorization, clearing, and settlement of payment transactions; and provision of fraud protection for account holders and assured payment for merchants. The company also offers a range of issuer processing services for participating issuers of Visa debit, prepaid, and ATM payment products. In addition, it provides electronic payment, risk management, and payment security solutions to online merchants; digital goods transactions services in online games, digital media, and social networks; and mobile financial services for mobile network operators and financial institutions in developing economies. The company offers its services under the Visa, Visa Electron, Interlink, and PLUS brands. Visa Inc. is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHEY ELLENVICE CHAIR RISK & PUB POLICYMar 02Sale277.004,7851,325,4459,837Mar 03 06:52 PM
RICHEY ELLENVICE CHAIR RISK & PUB POLICYFeb 09Sale267.417,9662,130,18814,622Feb 11 06:13 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERFeb 02Sale255.893,438879,75044,446Feb 04 06:57 PM
Sheedy William M.EVP CORP STRAT, M&A, GRNov 11Option Exercise0.0025,4320115,997Nov 13 06:49 PM
Sheedy William M.EVP CORP STRAT, M&A, GRNov 11Sale249.1725,4326,336,89190,565Nov 13 06:49 PM
RICHEY ELLENVICE CHAIR RISK & PUB POLICYNov 05Option Exercise0.001,125012,820Nov 07 05:45 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERSep 03Option Exercise0.004,867063,897Sep 04 04:35 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERSep 03Sale215.0714,5453,128,19349,352Sep 04 04:35 PM
PPG PPG Industries, Inc. daily Stock Chart
PPG [NYSE]
PPG Industries, Inc.
IndexS&P 500 P/E26.86 EPS (ttm)4.04 Insider Own0.40% Shs Outstand272.80M Perf Week2.74%
Market Cap29.60B Forward P/E16.62 EPS next Y6.53 Insider Trans-17.25% Shs Float272.70M Perf Month-5.40%
Income1.12B PEG2.39 EPS next Q1.63 Inst Own72.60% Short Float0.91% Perf Quarter-1.72%
Sales15.40B P/S1.92 EPS this Y34.10% Inst Trans0.06% Short Ratio1.50 Perf Half Y-3.25%
Book/sh18.63 P/B5.83 EPS next Y14.18% ROA6.40% Target Price129.09 Perf Year7.53%
Cash/sh4.29 P/C25.30 EPS next 5Y11.22% ROE19.70% 52W Range84.98 - 118.69 Perf YTD-5.53%
Dividend1.44 P/FCF- EPS past 5Y31.00% ROI13.60% 52W High-8.57% Beta1.25
Dividend %1.33% Quick Ratio1.10 Sales past 5Y4.60% Gross Margin43.20% 52W Low27.70% ATR2.24
Employees44400 Current Ratio1.50 Sales Q/Q0.40% Oper. Margin10.60% RSI (14)43.39 Volatility2.49% 2.04%
OptionableYes Debt/Eq0.91 EPS Q/Q-12.10% Profit Margin7.20% Rel Volume0.74 Prev Close108.57
ShortableYes LT Debt/Eq0.79 EarningsJul 16 BMO Payout24.80% Avg Volume1.66M Price108.52
Recom1.90 SMA20-2.75% SMA50-4.83% SMA200-2.30% Volume1,233,621 Change-0.05%
Jan-16-15Reiterated Argus Buy $238 → $271
Oct-17-14Reiterated RBC Capital Mkts Outperform $250 → $243
Oct-09-14Initiated RBC Capital Mkts Outperform $250
Jul-01-14Reiterated Deutsche Bank Buy $220 → $235
Apr-25-14Reiterated Argus Buy $216 → $224
Apr-21-14Reiterated Deutsche Bank Buy $213 → $220
Dec-06-13Reiterated Deutsche Bank Buy $195 → $210
Jul-22-13Reiterated UBS Neutral $148 → $156
Jul-22-13Reiterated RBC Capital Mkts Outperform $160 → $176
Jul-22-13Reiterated Barclays Equal Weight $157 → $167
Feb-12-13Resumed Barclays Equal Weight $149
Jan-23-13Reiterated Argus Buy $136 → $157
Jan-04-13Reiterated UBS Neutral $118 → $136
Dec-18-12Reiterated Deutsche Bank Buy $132 → $150
Aug-08-12Reiterated UBS Neutral $98 → $111
Jun-22-12Initiated Robert W. Baird Outperform $120
Apr-20-12Reiterated UBS Neutral $90 → $98
Apr-10-12Reiterated Barclays Equal Weight $101 → $105
Feb-01-12Reiterated Barclays Capital Equal Weight $92 → $101
Nov-18-11Reiterated Barclays Capital Equal Weight $85 → $93
Jul-30-15 08:14PM  Jim Cramer's 'Mad Money' Recap: Snap Out of It and Look at the Cold, Hard Facts at TheStreet
07:10PM  Cramer Remix: Oil stocks in the house of pain at CNBC
08:57AM  The Dow Chemical Co. Earnings Analysis: By the Numbers
Jul-29-15 08:09PM  10-Q for PPG Industries, Inc. at Company Spotlight
03:43PM  Marathon Petroleum Corporation Announces Election of New Director ACN Newswire
Jul-28-15 02:35PM  Here's your first look at the PPG Paints stores popping up in Pittsburgh at bizjournals.com
02:00PM  PPG Opens PPG PAINTS Stores in Pittsburgh Business Wire
12:25PM  Report: PNC to continue to anchor Nova Place at bizjournals.com
Jul-27-15 04:27PM  PPG INDUSTRIES INC Files SEC form 10-Q, Quarterly Report
Jul-23-15 10:04AM  Video: Watch Chinese CEO get busted on spy charges at CNBC
Jul-21-15 08:02AM  GLIDDEN Paint by PPG to Open Colortopia Exhibit in INNOVENTIONS at Epcot Business Wire
Jul-20-15 01:06PM  PPG INDUSTRIES INC Files SEC form 8-K, Change in Directors or Principal Officers
Jul-17-15 03:15PM  PPG Industries Appoints McGarry as New President & CEO - Analyst Blog
10:10AM  Company News for July 17, 2015 - Corporate Summary
08:41AM  PPG Industries (PPG) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
08:12AM  PPG Industries (PPG) Stock Declined After Earnings Release at TheStreet
08:00AM  Bunch's tenure marks time of transformation at PPG at bizjournals.com
01:53AM  Edited Transcript of PPG earnings conference call or presentation 16-Jul-15 6:00pm GMT
12:37AM  PPG Industries Profit Falls 13% on Restructuring Expenses at The Wall Street Journal
Jul-16-15 06:00PM  Cramer: I do not like this stock
02:00PM  PPG Industries Inc Earnings Call scheduled for 2:00 pm ET today
01:04PM  Time To Board The PPG Industries, Inc. (PPG) Ship, Post Earnings? at Insider Monkey
12:41PM  Trending Now: PPG Industries Inc.
12:10PM  PPG INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition
11:35AM  Cramer Loves PPG Industries but Hates to See Its CEO Step Down at TheStreet
11:01AM  PPG Industries Tops Q2 Earnings, Currency Drags Revenues - Analyst Blog
10:42AM  PPG Industries Profit Falls 13% on Restructuring Expenses at The Wall Street Journal
10:31AM  PPG Directors Announce Quarterly Dividend of 36 Cents Per Share Business Wire
09:54AM  Cramer's Stop Trading: PPG's CEO shock
09:29AM  PPG Q2 Earnings Rise, But Uneven Global Growth Seen at Investor's Business Daily
09:20AM  McGarry Elected PPG President and CEO Business Wire
08:23AM  PPG Industries (PPG) Q2 Earnings Trump Estimates, Sales Miss - Tale of the Tape
07:07AM  Q2 2015 PPG Industries Inc Earnings Release - Before Market Open
07:00AM  PPG Industries tops 2Q profit forecasts
06:51AM  PPG Reports Record Second Quarter Net Sales and Earnings Per Share Business Wire
Jul-15-15 08:54AM  Why PPG Industries (PPG) Might Surprise This Earnings Season - Tale of the Tape
Jul-14-15 08:02AM  Sherwin-Williams Primed To Show Big EPS Gain In Q2 at Investor's Business Daily
Jul-13-15 09:00AM  Is Another Earnings Beat Coming from PPG Industries (PPG)? - Analyst Blog
Jul-08-15 01:55PM  PPG Industries Launches Olympic Assure at Lowe's Stores - Analyst Blog
Jul-07-15 03:03PM  OLYMPIC Brand by PPG Introduces ASSURE Interior and Exterior Paint at LOWES Stores Business Wire
12:10PM  PPG Industries (PPG) Wraps Up Cuming Microwave Buyout - Analyst Blog
10:15AM  'The Book of Now' from PPG THE VOICE OF COLOR Program Provides Designers and Architects with Trends Color Palettes for Targeted Markets PR Newswire
Jul-06-15 02:15PM  PPG Industries Launches Sigma Sailadvance Coatings - Analyst Blog
Jul-01-15 02:15PM  PPG Industries Finishes $5 Million Coatings Plant Expansion - Analyst Blog
08:42AM  PPG Completes Acquisition of Specialty Coatings and Materials Manufacturer Cuming Microwave Business Wire
Jun-30-15 03:25PM  PPG Industries Gets NSF Certification for Duraform Clear Coat - Analyst Blog
10:40AM  PPG Honors Nine Excellent Suppliers Business Wire
08:11AM  PPG Completes $5 Million Expansion of Wuppertal, Germany, Coatings Plant Business Wire
Jun-29-15 03:35PM  PPG Industries' Powercron AdvantEdge Added by MetoKote - Analyst Blog
10:09AM  McGarry of PPG to Deliver Keynote Address at Pittsburgh Chemical Day Business Wire
Jun-26-15 01:37PM  MetoKote Only Supplier Of Powercron® AdvantEdge Electrocoat By PPG PR Newswire
Jun-25-15 02:32PM  PPG to Announce Second Quarter 2015 Results July 16 Business Wire
01:40PM  PPG Industries Launches Novaguard 810 Tank Storage Coating - Analyst Blog
Jun-23-15 05:40PM  Fast Tracker: AB Bhandari, PPG Industries at bizjournals.com
04:10PM  PPG Industries Unveils Glidden Grab-N-Go Paint at Walmart - Analyst Blog
Jun-22-15 03:01PM  GLIDDEN Paint by PPG Launches GRAB-N-GO Pre-Mixed Paint at WALMART Stores Business Wire
02:40PM  PPG Highlights Comex's Revenue & Cost Synergy Goals - Analyst Blog
Jun-18-15 05:28PM  PPG INDUSTRIES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
02:05PM  Painting a picture higher in PPG
01:23PM  PPG Hosts Meeting with Securities Analysts Business Wire
Jun-17-15 05:27PM  PPG Industries Provides Aircraft Parts to MITAC for Testing - Analyst Blog
08:47AM  PPG Completes First Colorful Communities Charitable-Giving Project in Asia Business Wire
Jun-16-15 07:03AM  Splits Calendar: PPG Industries splits before market open today (2:1 ratio)
Jun-15-15 12:30PM  PPG Industries (PPG) Snaps Up IVC Industrial Coatings - Analyst Blog
09:21AM  PPG Industries Is Set Up Well for More Upside at TheStreet
08:47AM  PPG Completes First Colorful Communities Charitable Giving Project in Europe Business Wire
Jun-11-15 08:11AM  PPG to Acquire IVC Industrial Coatings Business Wire
Jun-10-15 06:00PM  Cramer: The one thing we know in 2015
02:25PM  PPG Starphire Used in Glass Palace Celebrates 25 Years - Analyst Blog
Jun-08-15 09:40AM  PPG Industries Introduces Corrokleen 44 Rust Remover - Analyst Blog
07:00AM  5 Rocket Stocks That Are Ready for Blastoff at TheStreet
Jun-05-15 06:00AM  An investing strategy that doubles the market at MarketWatch
Jun-03-15 12:20PM  PPG Snaps Up Central American Paint Stores Network - Analyst Blog
11:24AM  PPG to buy Massachusetts-based Cuming Microwave Corp.
08:11AM  PPG to Acquire Specialty Coatings and Materials Manufacturer Cuming Microwave Business Wire
Jun-02-15 05:05PM  PPG Industries Introduces Duraform Polyester Coatings - Analyst Blog
10:36AM  Innova Dynamics And PPG Industries Have Established A Strategic Collaboration PR Newswire
10:02AM  PPG Architectural Coatings Honored by CIO Magazine as CIO 100 Award Winner Business Wire
08:57AM  PPG Industries buys 57-store Central American network
08:11AM  PPG Acquires Paint Stores Network in Central America Business Wire
May-29-15 01:40PM  PPG launches $10M global campaign at local charter school at bizjournals.com
10:30AM  PPG Launches $10 Million Colorful Communities Charitable Giving Initiative Business Wire
May-28-15 05:44PM  The Valspar Corp. Earnings Analysis: By the Numbers
May-27-15 04:05PM  PPG Earns Environmental Achievement Award for GREEN LOGIC Matrix Systems Business Wire
May-25-15 01:45PM  PPG Industries to Unveil Innovel Beverage-Can Coatings - Analyst Blog
May-21-15 02:30PM  PPG Industries Unveils Metal Coatings Color Selector Tool - Analyst Blog
May-20-15 03:08PM  GLIDDEN Paint by PPG Rolls Out THE SMARTER WAY TO WOW Campaign Business Wire
May-18-15 08:49AM  Five things to know today, and Heinz finally gets some love (after last week's snub) at bizjournals.com
May-15-15 08:09AM  These 5 Stocks Look Toxic for Your Portfolio in May at TheStreet
May-13-15 02:35PM  PPG Industries Launches Powercron AdvantEdge Electrocoat - Analyst Blog
May-12-15 03:15PM  PPG Industries' Solarban 60 on 3rd Certified 'Living' Building - Analyst Blog
01:00PM  PPG Announces Executive Appointments Business Wire
May-11-15 04:12PM  Defense attorney seeks psych exam in PPG trade secrets case
08:35AM  Five things to know today, and a bad day for Westinghouse Electric's parent company at bizjournals.com
May-08-15 11:22PM  FBI Alleges Former PPG Employee Gave Trade Secrets to Chinese Firm at The Wall Street Journal
07:00PM  Exec: The Laughing Stopped When We Became No. 1
05:24PM  PPG Agilon Performance Silica for Goodyear Tires - Analyst Blog
02:27PM  Feds: Ex-PPG employee stole trade secrets for Chinese firm
May-07-15 07:53PM  Jim Cramer's 'Mad Money' Recap: The 5 Ingredients in Today's Rally Recipe at TheStreet
07:24PM  Cramer Remix: Lightning Round history made at CNBC
PPG Industries, Inc. manufactures and distributes coatings, specialty materials, and glass products. The company's Performance Coatings segment provides coatings products for automotive and commercial transport/fleet repair and refurbishing; light industrial and specialty coatings for signs; sealants, coatings, maintenance cleaners, and transparencies for commercial, military, regional jet and general aviation aircraft, and transparent armor for specialty applications; and chemical management services. This segment also offers protective and marine coatings and finishes for the protection of metals and structures to metal fabricators and heavy duty maintenance contractors, as well as to the manufacturers of ships, bridges, and rail cars; architectural coatings used by painting and maintenance contractors, and consumers for decoration and maintenance of residential and commercial building structures; and purchased sundries to painting contractors and consumers. Its Industrial Coatings segment provides adhesives and sealants for the automotive industry, and metal pretreatments and related chemicals for industrial and automotive applications; precipitated silicas for tire, battery separator, and other markets; substrates used in radio frequency identification tags and labels, e-passports, drivers' licenses, and identification cards applications; organic light emitting diode materials for use in displays and lighting; optical lens materials and photochromic dyes for optical lenses and color-change products. The company's Glass segment produces flat glass and fiber glass for commercial and residential construction, and wind energy, energy infrastructure, transportation, and electronics industries. PPG Industries, Inc. sells its products through owned stores, home centers, paint dealers, concessionaires, other consumer retail outlets, independent distributors, and directly to customers. The company was founded in 1883 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHENHAGEN MARTINDirectorApr 15Option Exercise0.0063008,867Apr 17 02:36 PM
HOOPER MICHELE JDirectorApr 15Option Exercise0.0063006,255Apr 17 02:31 PM
BERGES JAMES GDirectorApr 15Option Exercise0.0063004,369Apr 17 02:12 PM
MCGARRY MICHAEL HPresident & COOFeb 26Option Exercise89.946,664599,36046,371Mar 02 04:04 PM
MCGARRY MICHAEL HPresident & COOFeb 26Sale235.606,6641,570,03639,707Mar 02 04:04 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentFeb 25Option Exercise89.9412,6641,139,00033,488Feb 27 04:03 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentFeb 25Sale236.3519,3784,579,99414,110Feb 27 04:03 PM
BUNCH CHARLES EChairman and CEOFeb 23Sale236.1720,0004,723,370380,536Feb 24 04:05 PM
BOST GLENN E IISr. VP & Gen. CounselFeb 20Option Exercise89.9414,5271,306,55836,365Feb 24 04:02 PM
BUNCH CHARLES EChairman and CEOFeb 20Sale233.9020,0004,678,091400,536Feb 24 04:05 PM
BOST GLENN E IISr. VP & Gen. CounselFeb 20Sale233.7819,8974,651,42116,468Feb 24 04:02 PM
BUNCH CHARLES EChairman and CEOFeb 18Option Exercise89.9470,7716,365,144444,949Feb 19 04:04 PM
BUNCH CHARLES EChairman and CEOFeb 18Sale234.4270,77116,590,277374,178Feb 19 04:04 PM
BUNCH CHARLES EChairman and CEOFeb 17Option Exercise89.9470,7716,365,144444,949Feb 19 04:04 PM
BUNCH CHARLES EChairman and CEOFeb 17Sale235.4970,77116,666,094374,178Feb 19 04:04 PM
RICHENHAGEN MARTINDirectorFeb 15Option Exercise0.001,27908,237Feb 17 09:03 AM
HOOPER MICHELE JDirectorFeb 15Option Exercise0.001,27905,625Feb 17 09:00 AM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevJan 23Option Exercise83.908,290695,53130,984Jan 27 03:47 PM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevJan 23Sale229.198,2901,899,98522,694Jan 27 03:47 PM
BOST GLENN E IISr. VP & Gen. CounselNov 14Option Exercise75.032,975223,21419,443Nov 17 10:30 AM
BOST GLENN E IISr. VP & Gen. CounselNov 14Sale205.112,975610,20216,468Nov 17 10:30 AM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevAug 14Option Exercise86.579,000779,10031,694Aug 15 09:01 AM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevAug 14Sale201.139,0001,810,19222,694Aug 15 09:01 AM
HON Honeywell International Inc. daily Stock Chart
HON [NYSE]
Honeywell International Inc.
IndexS&P 500 P/E18.89 EPS (ttm)5.58 Insider Own0.10% Shs Outstand781.76M Perf Week1.02%
Market Cap82.38B Forward P/E15.70